Seventh Americas Hepatopancreatobiliary Congress ANNUAL SCIENTIFIC SESSION & POST GRADUATE PROGRAM April 19–22, 2007 Bally's Hotel Las Vegas, Nevada

Thursday, April 19^th, 2007

7:30 – 5:30 p.m.	Meeting Registration	(Lobby, Bally's Hotel)
8:00 – 5:15 p.m.	Postgraduate Course	(Pacific Ballroom)
	Benign Pancreatic Diseases

8:00 – 8:25 a.m.

Pancreatitis	Speakers
Intracellular Changes during Acute Pancreatitis	M. Steer, MD
Scoring and Classification Systems for Pancreatitis: Strengths and weaknesses of each	Richard Bell, MD

8:25 – 9:30 a.m.

IMAGING FOR ACUTE PANCREATITIS

MRCP versus ERCP	Eric VanSonnenberg, MD
CT Grading of Acute Pancreatitis	Todd Bauer, MD
Endoscopic Ultrasound	Paul Yeaton, MD
Intraoperative Ultrasound	Junji Machi, MD
Panel Discussion (to 9:30)

9:30 – 10:50 a.m.

PANCREATITIS BY ETIOLOGY

Alcoholic Pancreatitis: Unique Aspects of Management	David McFadden,MD,
Gallstone Pancreatitis: Role of ERCP in Diagnosis and Therapy	Gerald Larson, MD
Gallstone Pancreatitis: Role of Surgery	Michael Sarr, MD
Autoimmune Pancreatitis: Is It a Surgical Disease?	Markus Buechler, MD
Management of Idiopathic Recurrent Pancreatitis	Howard Reber, MD
Panel Discussion (to 10:50)

10:50 – 11:50 am

ACUTE NECROTIZING PANCREATITIS

Role of Percutaneous Management	Eric VanSonnenberg, MD
Role of Endoscopic Management	Paul Yeaton, MD
Role of Surgical Management	Ted Pappas, MD
Role of Multimodal Management: Surgery and Drains	William Traverso, MD
Panel Discussion (to 11:50)

11:50 – 1:30

Lunch Break to 1:30

1:30 – 2:20 pm

PANCREATIC CYSTS AND PSEUDOCYSTS

Diagnosis and Therapy of Benign Cystic Neoplasms of the Pancreas	Henry Pitt, MD
Pancreatic Pseudocysts: Role of Endoscopic Management	Jeff Ponsky, MD
Pancreatic Pseudocysts: Role of Surgical Management	Juan Pekolj, MD
Panel (to 2:20)

2:20 – 4:00 pm

CHRONIC PANCREATITIS

Endoscopic Therapy	William Nealon, MD
Surgical Therapy	Charles Frey, MD
Frey Procedure	Thomas van Gulik, MD
Beger Procedure	Keith Lillemoe, MD
Central Resection	David Adams, MD
Distal Pancreatectomy	Robert G.Martindale, MD, PhD
Nutritional Support during Acute Pancreatitis	Jeffrey Drebin, MD
Pain and Narcotic Issues During Chronic Pancreatitis
Panel Discussion (to 4:00)

4:00 – 4:20 pm

PANCREAS DIVISUM

Etiology, Pathophysiology, and Diagnosis	Juan Sarmiento, MD
Endoscopic vs. Surgical Therapy	Maurice Arregui, MD

4:20 – 5:15 pm

PANCREATIC TRANSPLANTATION

Update on Islet Cell Approach	Kenneth Brayman, MD
Benchmark Outcomes for Kidney/Pancreas Transplantation	Rainer Gruessner, MD
The Bioartificial Pancreas	Boris Kovatchev, Ph.D.
Panel Discussion (to 5:15)

5:30 – 7:00 p.m.	Reception	(Exhibit Hall, parris Hotel)
7:00 – 9:00 p.m.	Symposium:	(Pacific Ballroom)
	Hepatocellular Carcinoma: Transplant, Resect, or Ablate? (sponsored by Valleylab, Tyco Healthcare)

Friday, April 20^th, 2007: General Sessions

7:30 – 5:30 p.m.	Meeting Registration	(Lobby, Bally's Hotel)
6:30 – 7:55 a.m.	Industy Sponsored Breakfast Symposium	(Las Vegas Rooms)
	Procedural Advances in Liver Resection using Endoscopic Stapling Techniques
	Joseph F. Buell, MD Louisville, KY (sponsored by AutoSuture, United States Surgical, Tyco Healthcare)
	Resin 90Y Radioembolization (RE) an Emerging Therapy for the Treatment of Unresectable Colorectal Liver Metastasis
	Andrew S. Kennedy, MD, Cary, NC (sponsored by Sirtex Medical Inc.)
	Novel and Emerging Techniques in the Surgical and Trans-Arterial Management of Hepatic Malignancy
	Bloodless Laparoscopic Liver Resection with the Habib4X
	David A. Geller, MD, Pittsburgh, PA
	Parenchymal Dissection in the Cirrhotic Liver: Emerging Techniques
	Lawrence Wagman, MD, Duarte, CA
	Laparoscopic Radiofrequency Ablation: Practical Tips for Optimizing Techniques and Patient Selection
	Allent E. Siperstein, MD, Cleveland, OH
	Efficacy and Safety of Doxorubicin Eluting Beads in the Treatment of Hepatocellular Carcinoma
	David K. Imagawa, MD, PhD, Irvine, CA
8:00 – 9:30 a.m.	President's Plenary Session and Young Investigator's Awards (PPL – 01)(Pacific Ballroom)
	Moderators: Sean Mulvihill, MD, Salt Lake City UT and Bruce Schirmer, MD, Charlottesville, VA

	Abstract Number 1–7
	1.) RNA Stability Regulates Differential Expression Of The Metastasis Protein, Osteopontin, In Hepatocellular Cancer
	Sirisha Emani, PhD, Jinping Zhang, MD, PhD, Luci Guo, Hongtao Guo, MD, PhD, Paul C Kuo, MD, Duke Univ Med Ctr, Durham, NC.
	2.) Attenuated Listeria Strains Depleted of Regulatory T cells Effectively Target Hepatic Colorectal Metastases
	Kiyoshi Yoshimura, MD, PhD, Lindsay Sue Laird, Kristen Faith Meckel, Drew Mark Pardoll, MD, PhD, Richard David Schulick, MD, Johns Hopkins Medical Institutions, Baltimore, MD.
	3.) Treatment of Unresectable Cholangiocarcinoma with Gemcitabine-based Transcatheter Arterial Chemoembolization (TACE): Single-Institution Experience
	Niraj Gusani, MD, Fady Balaa, MD, Jennifer Steel, MD, David A Geller, MD, Wallis Marsh, MD, Brain Carr, MD, PhD, T. Clark Gamblin, UPMC Liver Cancer Center, University of Pittsburgh, Pittsburgh, PA.
	4.) Pancreatic Transection Margin at the Time of Pancreaticoduodenectomy: Clinical Implications of a Positive Margin
	Curtis J Wray, MD, Henry F Gomez, MD, Jean Nicholas Vauthey, MD, Eddie K Abdalla, MD, Jeffrey E Lee, MD, Huamin Wang, MD, PhD, Douglas B Evans, MD, Peter Wt Pisters, D, University of Texas MD Anderson Cancer Center, Houston, TX.
	5.) Significance of the anti-inflammatory factor hemeoxgenase-1 (HO-1) for the function of tumor infiltrating macrophages in human hepatocellular carcinoma
	Christoph Benckert, MD, Armin Thelen, MD, Thorsten Cramer, MD, Anotonino Spinelli, MD, Peter Neuhaus, MD, Sven Jonas, MD, Charité, Campus Virchow Klinikum, Universitätsmedizin Berlin, 13353 Berlin, Germany.
	6.) C-reactive protein as a predictor of prognosis following curative resection for colorectal liver metastases
	Vincent Kh Wong, Hassan Z Malik, MD, Zaed Hamady, Ahmed Al-mukhtar, Dhanny Gomez, K Rajendra Prasad, Giles J Toogood, Peter A Lodge, MD, St. James's University Hospital, Leeds, United Kingdom.
	7.) Long-Term Outcomes Following Liver Transplantation for Hepatic Hemangioendothelioma: The UNOS Experience from 1987 to 2005
	Joel A Rodriguez, Natasha S. Becker, MD, Neal R. Barshes, MD, Christine A. O'mahony, MD, Thomas A. Aloia, MD, John A. Goss, MD, Baylor College of Medicine, Houston, TX.
9:35 – 9:45 a.m.	Introduction of the President
	Bruce Schirmer, MD – President Elect, AHPBA, University of Virginia, Charlottesville, VA
9:45 – 10:15 a.m.	Presidential Address
	Sean Mulvihill, MD – President, AHPBA, University of Utah, Salt Lake City, UT
	“Quality and Outcomes Measures in HPB Surgery”

10:15 – 10:30 a.m.	Coffee break	(Paris Hotel)
10:30 – 12:15 p.m.	AHPBA / SAGES Joint Symposium	(Paris Hotel)
	Ablation Technologies
	Moderators: David Iannitti, MD and Frederick Greene, MD, Charlotte, NC
	Introduction: David Iannitti, MD
	Speakers:Robert Martin, MD, Louisville, KY
	Physics of Ablation
	Scott Helton, MD, New Haven, CT
	Limitations of Ablation
	Anton Bilchik, MD, Los Angeles, CA
	Long-Term Outcomes for CRC Mets
	Ronnie Poon, MD, Hong Kong, P. R. China
	Long-Term Outcomes for HCC
	Joseph Buell, MD, Louisville, KY
	Ablation for HCC: A Bridge to Liver Transplantation
	David Lloyd, MD, Leicester, UK
	Microwave: Physics and UK Experience
	David Iannitti, MD, Charlotte, NC
	Microwave: The US Experience
	Michael Choti, MD, Baltimore, MD
	New Technologies and Future Direction
	Panel Discussion Faculty
12:15 – 1:00 p.m.	Lunch and Exhibit Viewing	(Paris Hotel)
1:00 – 1:25 p.m.	State of the Art Address	(Pacific Ballroom)
	“Assessing and Managing the Future Liver Remnant”
	Speaker:    J. Nicolas Vauthey, MD, Houston, TX
1:30 – 3:30 p.m.	Oral Posters	(Pacific Ballroom)
	Oral Posters (OP – 01) Transplantation
	Moderators: Juan Sanabria, MD, Cleveland, OH

	Abstract Number 8 – 17
	8.) Metabolic changes in the pig liver during warm ischemia and reperfusion measured by microdialysis
	Anne-sofie Kannerup, MD, Peter Funch-jensen, MD, PhD, Henning Gronbaek, MD, PhD, Rasmus Langelund, MD, Frank Viborg Mortensen, MD, PhD, Aarhus University hospital, Århus C, Dk-8000, Denmark.
	9.) Synthetic TACE Inhibitor Y-41654 Improves Hepatic Ischemia Reperfusion Injury
	Ari J Cohen, MD, George Loss, MD, PhD, Zhenya Tang, MD, PhD, Ochsner Clinic Foundation, New Orleans, LA.
	10.) Gender Differences Influence NFkB-dependent Responses to Hepatic Ischemia-Reperfusion
	Jane M Liaw, MD, Travis J Pagliara, None, Krista A Csontos, None, Sucharita Das, MS, Sabarinathan Ramachandran, PhD, Thalachallour Mohanakumar, PhD, William C Chapman, MD, Washington University, St Louis, MO.
	11.) A prolonged graft cold ischaemia time is significantly associated with increased recipient mortality in liver transplant recipients
	Martin W Drage, MD, MBBS, Yumin Li, MBBS, Raaj Praseedom, MBBS, University of Cambridge, Cambridge, United Kingdom.
	12.) Outcomes of Liver Allografts that have Experienced Surgical or Traumatic Injury
	John Renz, MD, PhD, James Guarrera, MD, Ben Samstein, MD, Dominique Jan, MD, Sarah Bellemare, MD, Milan Kinkhabwala, MD, Jean Emond, MD, Columbia University, New York, NY.
	13.) Are Lacerated Livers Transplantable?-A case report with review of the literature
	Hamidreza Fonouni, MD, Arianeb Mehrabi, MD, PhD, Bruno Schmied, MD, PhD, Peter Kienle, MD, PhD, Jürgen Weitz, MD, PhD, Markus W Büchler, MD, PhD, Jan Schmidt, MD, PhD, University of Heidelberg, Heidelberg, Germany.
	14.) Donor age affects immediate but not longterm survival following liver transplantation
	Markus Selzner, MD, Nazia Selzner, MD, PhD, George Therapondas, MD, Stuart Mccluskey, MD, Ian Mcgilvray, MD, PhD, Toronto General Hospital, Toronto, ON, Canada.
	15.) Withdrawn
	Amanda Cooper, MD, Shane Mangus, MD, MPH, Rodrigo Vianna, MD, Jonathan Fridell, MD, Mary Maluccio, MD, MPH, Joseph Tector, MD, PhD, Indiana University School of Medicine, Indianapolis, IN.
	16.) Plasmapheresis in Severe Coagulopathy and Severe Graft Dysfunction in Liver Transplantation: Is it Worth the Risk?
	Robert L Shapiro, John W Mcgillicuddy, MD, Zachary P Evans, Kenneth D Chavin, MD, PhD, Medical University of South Carolina, Charleston, SC.
	17.) Islet isolation from non-heart beating donor and evaluation of donor factors to affect isolation results.
	Michihiro Maruyama, MD, PhD, Takashi Kenmochi, MD, PhD, Kenichi Saigo, MD, PhD, Naotake Akutsu, MD, PhD, Chiba-east National Hospital, Chiba, Japan.
	Oral Posters (OP – 02) Biliary I: Malignant
	Moderators: Sean Cleary, MD, Toronto, ON and Palepu Jagannath, MS, Mumbai, India

	Abstract Numbers 18 – 28
	18.) Composite Tumor of the Ampulla of Vater: Signet-ring Cell and Neuroendocrine Carcinoma -A Case Report
	Kunmoo Choi, MD, PhD, Daiwoon Eom, MD, Univ. of Ulsan,GangNeung Asan Medical Center, Dept. of Surgery, Gangneung, Republic of Korea; Univ. of Ulsan,GangNeung Asan Medical Center, Dept. of Pathology, Gangneung, Republic of Korea.
	19.) Intrahepatic Papillary Cholangiocarcinoma: A Rare Cholangiocarcinoma With A More Favorable Prognosis
	Christopher D Anderson, MD, Majella Doyle, MD, William C Chapman, MD, Jeffrey A Lowell, MD, Section of Abdominal Transplantation, Washington University in St. Louis, St Louis, MO.
	19a.) Synchronic cancer of the biliary tract. Case report and review of the literature.
	Néstor A Gómez, Jerónimo J Gaibor, Jorge L Mejillón, Jorge A Zapatier, Paola E Vargas, Department of Surgery, Medicine School, University of Guayaquil and Institute of Digestive Diseases “Esperanza Foundation”, Guayaquil, Ecuador; Institute of Digestive Diseases “Esperanza Foundation”, Guayaquil, Ecuador.
	20.) Surgery for Advanced Klatskin's tumor with Vascular Involvement
	Huang Ching Wen, MD, Chen Hong-Yaw, MD, Ker Chen-Guo, PhD, FACS, Juan Chung-Chou, PhD, Yuan's General Hospital, Kaohsiung, Taiwan.
	21.) Recurrence-Free Survival and Pattern of Recurrence Following Resection of Hilar Cholangiocarcinoma
	Fumito Ito, MD, PhD, Robert Rettammel, None, Mark Bean, None, David M Mahvi, MD, Layton F Rikkers, MD, Sharon M Weber, MD, University of Wisconsin, Madison, WI.
	22.) A Case Of Combined Resection For Synchronous Primary Carcinomas Of Gallbladder And Duodenum
	Chol Kyoon Cho, MD, PhD, Hyun Jong Kim, MD, PhD, Yang Seok Koh, MD, FRCP, Soon Ju Jeong, MD, Jung Chul Kim, MD, PhD, Young Hoi Hur, MD, Chang Hwan Park, MD, PhD, Wan Sik Lee, MD, PhD, Sung Kyu Choi, MD, PhD, Jong Sun Rew, MD, PhD, Sei Jong Kim, MD, PhD, Yong Yeon Jeong, MD, PhD, Sang Soo Shin, MD, Jae Hyuk Lee, MD, PhD, Young Eun Joo, MD, PhD, Chonnam National University Medical School, Gwangju, Republic of Korea.
	23.) Primary Non-Hodgkin's Lymphoma of the Gallbladder
	Siddharth K Bhende, Burt Cagir, Guthrie/RPH, Sayre, PA.
	24.) A single-center experience on the surgical treatment of the gallbladder carcinoma
	Yoshikazu Toyoki, MD, PhD, Kenichi Hakamada, MD, PhD, Shunji Narumi, MD, PhD, Mutsuo Sasaki, MD, PhD, Hirosaki University School of Medicine, Hirosaki, Japan.
	25.) Incidentally detected T3/T4 carcinoma of gall bladder: the race against time and disease tide
	Nihar R Dash, MS, Pawan Kumar, MS, Sujoy Pal, MS, Peush Sahni, MD, Tushar Kanti Chattopadhyay, MS, AIIMS,New Delhi,India, New Delhi, India.
	26.) Surgical Treatment of Gallbladder Cancer: A Population Based Analysis
	Natalie G Coburn, MD, MPH, Kouros Moozar, MD, Jensen C. C. Tan, MD, Calvin Law, MD, MPH, University of Toronto, Toronto, ON, Canada.
	27.) Effectiveness of the intra-arterial infusion chemotherapy for the liver metastasis of the recurrence of lower bile duct cancer.
	Hideaki Andoh, MD, PhD, Yoshio Kobayashi, MD, Yuich Tanaka, MD, Manabu Onuki, MD, Koji Fukuda, MD, Nakadori General Hospital, Akita, Japan.
	28.) Usefullness of gemcitabine combined with 5-fluorouracil and cisplatin(GFP) in patients for advanced biliary tract cancer.
	Kozo Yoshikawa, Yuji Morine, Tetsuya Ikemoto, Satoru Imura, Tomoharu Yoshizumi, Mitsuo Shimada, Department of Surgery, Tokushima, Japan; University of Tokushima, Tokushima, Japan.
	Oral Posters (OP – 03) Basic Science I
	Moderators: David Linehan, MD, St. Louis, MO and Kevin Staveley-O'Carroll, MD, Hershey, PA

	Abstract Numbers 29 – 40
	29.) The Development Of A Swine Model Of Secondary Liver Tumors From A Genetically Induced Swine Fibroblasts Cell Line.
	Rime Abbas, MD, Ann Robinson, Stacy Adam, PhD, Mike Mcgee, MD, Julian Kim, MD, PhD, Christopher M Counter, PhD, Juan R Sanabria, MD, University Hospitals-Case Medical Center-Case WR University, Cleveland, OH; Duke University, Durham, NC.
	30.) Dendritic cells generation from peripheral blood mononuclear cells obtained from jaundiced patients with pancreatic adenocarcinoma.
	Andre S Matheus, Mariza Treglia, Jose Jukemura, MD, PhD, Jose Eduardo M. Da Cunha, MD, PhD, Marcel C. C. Machado, MD, PhD, Jose Alexandre M. Barbuto, MD, PhD, University of Sao Paulo, Sao Paulo, Brazil.
	31.) Tolerance to a tumor associated antigen is dependent upon the site of expression and antigen load.
	Diego Avella, MD, Luis Garcia, MD, Eric Kimchi, MD, Kevin Staveley- O' Carroll, MD, PhD, Penn State University, Hershey, PA.
	32.) Fibroblasts Promote Pancreatic Cancer Cell Growth In Vitro
	Qiang Dai, PhD, Matthew A. Firpo, PhD, Jill D. Coursen, MS, Sean J. Mulvihill, MD, University of Utah, Salt Lake City, UT.
	33.) Thalidomide Treatment of Developing Hepatocellular Carcinoma: An In-Vivo Study in Rat
	Jeng Kuo-shyang, MD, Kuo-ming Chang, MD, Mackay Memorial Hospital, Taipei, Taiwan.
	34.) Is it effective to treat hepatocellular carcinoma in rats by TMPyP4?
	Jeng Kuo-shyang, MD, Kuo-ming Chang, MD, Mackay Memorial Hospital, Taipei, Taiwan.
	35.) Genetic Expression Profile of Signal Transduction(ST) Pathways in w-3 Fatty Acid Treated Pancreatic Cancer Cells
	Anthony Razzak, Justin Hering, MD, Trish Babcock, MS, Joseph Espat, MD, UIC, Chicago, IL.
	36.) Tumor genetics and signaling response to gemcitabine correlate with treatment effect of gemcitabine-based molecular targeting strategies.
	Bryan K Holcomb, MD, Michele Yip-schneider, PhD, Jennifer Dixon, MD, Jason Kennard, MD, Julie Mahomed, Eric Wiebke, MD, Judith Sebolt-leopold, PhD, C.max Schmidt, MD, PhD, Indiana University School of Medicine, Indianapolis, IN; Pfizer Pharmaceuticals, Ann Arbor, MI.
	37.) A Novel Conditionally Replicative Adenovirus Gene Therapy Targeting Overexpression of Chemokine Receptor CXCR4 in a Pancreatic Cancer Cell Line
	Neal Holm, MD, Kerry W. Byrnes, MD, Bradford Siegele, MS, Benjamin Li, MD, Yoshi Odaka, PhD, Michael Mathis, PhD, Quyen Chu, MD, LSU Health Sciences Center, Shreveport, LA.
	38.) Peptide YY (PYY) And Inositol Hexaphosphate (IP6): Evaluation Of Natural And Novel Compounds For The Treatment Of Pancreatic Cancer
	Brian Mcmillan, Dale Riggs, Barbara J Jackson, David W Mcfadden, MD, West Virginia University, Morgantown, WV.
	39.) Synergistic Effect of Simultaneous 5-LOX and COX-2 Inhibition on Pancreas Cancer Cell Growth In Vitro
	Jill D. Coursen, MS, Tracy M. Covey, None, Kornelia Edes, MS, Kenneth M. Boucher, PhD, Matthew A. Firpo, PhD, Frank A. Fitzpatrick, PhD, Sean J. Mulvihill, MD, University of Utah, Salt Lake City, UT.
	40.) Inhibition of Pancreatic Cancer Cell Proliferation by a Combination Treatment Strategy Employing n-3 Fatty Acids and Gemcitabine.
	Justin Hering, MD, Anthony Razzak, Sean Garrean, MD, Babcock Tricia, Jose Trevino, MD, Ws Helton, MD, N Espat, MD, UIC, Chicago, IL.
	Oral Posters (OP – 04) Pancreas I: Outcomes
	Moderators: John Christein, MD, Birmingham, AL and Bob Jury, MD, Detroit, MI

	Abstract Numbers 41 – 52
	41.) Mortality rates for Pancreaticoduodenectomy (Whipple's procedure) in a medium volume, public funded system.
	Jeremy Lipschitz, MD, Department of Surgery, Health Sciences Centre, University of Manitoba, Winnipeg, MB, Canada.
	42.) The Outcome Of Surgical Management Of Pancreatic And Non Pancreatic Periampullary Tumors
	Madhava Pai, Paolo Limongelli, Andrew Healey, Stamp Gordon, Nagy Habib, Robin Williamson, Long Jiao, Hammersmith Hospital, Imperial College,, London, United Kingdom.
	43.) Feasibility and safety of pancreaticodudenectomy (the Whipple procedure) in a high volume community hospital.
	Roozbeh Rassadi, MD, Allison Vo, RN, Dhiresh Rohan Jeyarajah, MD, Dallas Methodist Medical Center, Dallas, TX.
	44.) Safety of pancreatic resection in the elderly
	Tsuneo Tanaka, MD, PhD, Naoki Kagawa, MD, PhD, Yasuhiro Matsugu, MD, PhD, Hideki Nakahara, MD, PhD, Hiroshima Prefectural Hospital, Hiroshima, Japan.
	45.) Community Hospital Outcomes of Whipple Procedure-For Regionalization of Care
	Pascal R Fuchshuber, MD, PhD, FACS, R Kwan, MD, C K Chang, MD, Kaiser Permanente Medical Center, Walnut Creek, CA; Department of Surgery, UCSF-East Bay, Oakland, CA.
	46.) Outcome following resection for pancreatic cancer based on surgeon experience: the long and short of it.
	Emmanuel E Zervos, MD, Nasreen A Vohra, MD, John E. Mullinax, Alexander S. Rosemurgy, MD, University of South Florida College of Medicine, Tampa, Fl 33612, FL.
	47.) Pancreatic Cancer Screening Program: Transcutaneous Ultrasound, Magnetic Resonance Imaging, and Psychosocial Measures
	Heidi Rothenmund, MS, Stephanie Wilson, MD, Masoom Haider, MD, Saumea Thayalan, Kara Semotiuk, MS, Spring Holter, MS, Poala Ardiles, Aletta Poll, MS, Steven Narod, MD, Susan Armel, MS, Anne Summers, MD, David Hogg, MD, Kate Butler, MS, Mary Jane Esplen, PhD, Steven Gallinger, MD, Mount Sinai Hospital, Toronto, ON, Canada; University Health Network, Toronto, ON, Canada; Women's College Hospital, Toronto, ON, Canada; Toronto Sunnybrook Regional Cancer Centre, Toronto, ON, Canada; University of Toronto, Toronto, ON, Canada.
	48.) Treatment of Pancreatic Cancer In A Single Payer Network
	Ck Chang, MD, Js Choi, MD, Rc Liu, MD, Sk Liu, MD, T Rolle, MD, Pr Fuchshuber, MD, PhD, Kaiser Permanente, Walnut Creek, CA.
	49.) Practice variation and outcomes of pancreaticoduodenectomy: A population-based study
	Anand Govindarajan, MD, Jensen C. C. Tan, MD, Natalie G. Coburn, MD, MPH, Calvin H. L. Law, MD, MPH, University of Toronto, Toronto, ON, Canada.
	50.) Outcome of distal pancreatectomy for pancreatic adenocarcinoma
	Brian K Goh, Yu-meng Tan, MBBS, Peng-chung Cheow, MBBS, Yaw-fui Chung, MBBS, Pierce K. H. Chow, PhD, Wai-keong Wong, MBBS, London Lucien Ooi, MD, Singapore General Hospital, Singapore, Singapore.
	51.) Trends in the Epidemiology and Treatment of Pancreatic Cancer
	Anthony Chan, Ajith Siriwardena, Irvin Modlin, Mark Kidd, HPB Research Group, Manchester, United Kingdom; Gastric Pathobiology Research Group, New Haven, CT.
	52.) The Natural History of Resected Pancreatic Cancer Without Adjuvant Treatment
	Emmanuel Zervos, MD, Sam Al-saadi, MD, Jonathan Hernandez, MD, Desiree Villadolid, MPH, Amy Collins, Jennifer Cooper, Rachel Gillman, Nasreen Vohra, MD, Alexander Rosemurgy, MD, University of South Florida And Tampa General Hospital, Tampa, FL.
	Oral Posters (OP – 05) Liver I: Malignant
	Moderators: Sharon Weber, MD and Madison, WI and D. Rohan Jeyarajah, MD, Dallas, TX

	Abstract Numbers 53 – 64
	53.) Accuracy of 3 Dimensional Liver Images reconstructed from CT scans using computer software: Prospective Non-Randomised Study
	Osama M Damrah, Paul Tait, Long Jiao, Nagy Habib, Ruben Canelo, Hammersmith Hospital-Imperial College London, London, United Kingdom.
	54.) Trans-Arterial Chemoembolization For Hepatocellular Carcinoma-Institutional Experience
	Osama M Damrah, Madhav Pai, Paul Tait, Nagy Habib, Ruben Canelo, Long Jiao, Hammersmith Hospital-Imperial College London, London, United Kingdom.
	55.) Liver resection for hepatocellular carcinoma in cirrhotic patients-how dysfunctioning liver is not beneficial?
	Cheng Chung Wu, MD, Shao Bin Cheng, MD, Yee Ji Jan, MD, Dah Cherng Yeh, MD, Taichung veterans General Hospital, Taichung, Taiwan.
	56.) A perioperative complication-free course without a high serum hyaluronate level ensures prolonged disease-free survival and overall survival after hepatectomy for hepatocellular carcinoma
	Toru Mizuguchi, MD, PhD, Tadashi Katsuramaki, MD, PhD, Minoru Nagayama, MD, PhD, Makoto Meguro, MD, PhD, Toshihiko Nishidate, MD, PhD, Takayuki Nobuoka, MD, Yasutoshi Kimura, MD, PhD, Koji Yamaguchi, MD, PhD, Tomohisa Furuhata, MD, PhD, Koichi Hirata, MD, PhD, Sapporo Medical University, Sapporo, Japan.
	57.) Prognostic Significance of p53, beta-Catenin, and Alpha-Fetoprotein Expression in Patients with Surgically Resected Hepatocellular Carcinoma
	Ana L Gleisner, MD, Michael Torbenson, MD, Timothy M Pawlik, MD, MPH, Lia R Assumpcao, MD, Michael A Choti, MD, MBA, Johns Hopkins Hospital, Baltimore, MD.
	58.) Surgical Treatment of Hepatocellular Carcinoma: Which Factors Predict Recurrence?
	Carlo M Contreras, MD, Jake Behrens, None, Clifford S Cho, MD, Robert Rettammel, MS, Mahvi M David, MD, Rikkers F Layton, MD, Weber M Sharon, MD, University of Wisconsin Hospital & Clinics, Madison, WI.
	59.) Results of treatment in 245 Mexican patients with hepatocellular carcinoma.
	Ricardo Joaquin Mondragón-sánchez 80, MD, PhD, Ofelia Arias-arias 2005, Elvira Gómez-gómez 2003, MD, Rodrigo Jasso-barranco 2006, MD, Alicia Ivette López-estrada 2006, Brenda Elena Aguilar-álvarez 2006, MD, issemym, Toluca, Mexico.
	60.) Fluorine-18-FDG-PET could be an effective surveillance modality for detection of distant metastasis in hepotocellular carcinoma
	Kazuaki Nakanishi, MD, PhD, Toshiya Kamiyama, MD, PhD, Takahito Nakagawa, MD, PhD, Hideki Yokoo, MD, PhD, Satoru Todo, MD, PhD, Hokkaido Univ, Sapporo, Japan.
	61.) Results Of Yttrium-90 Microsphere Treatment In The Management Of Unresectable Liver Cancer
	Osama M Damrah, Hapreet Wasan, Nagy A Habib, Ruben Canelo, Long R Jiao, Hammersmith Hospital, London, United Kingdom.
	62.) Y-90 Resin Microsphere Selective Internal Radiation Treatment in Primary and Metastatic Liver Cancer: Objective Response and Therapeutic Ratio Analysis
	Seza A Gulec, MD, Geraldine Mesoloras, MS, Howard Wiarda, MD, Kenneth Pennington, MD, Daniel Bruetman, MD, James Wheeler, MD, PhD, Richard Hostetter, MD, Douglas Schwartzentruber, MD, Center for Cancer Care at Goshen Health System, Goshen, IN.
	63.) Identification of novel single nucleotide polymorphism in the promoter region of human alpha-fetoprotein (AFP) gene in hepatocellular carcinoma (HCC)
	George G Chen, PhD, Rocky Lk Ho, John Wong, Kit Fai Lee, Paul Bs Lai, The Chinese University of Hong Kong, Hong Kong, Hong Kong.
	64.) Oncolytic Mutant Herpes Virus Kills Hepatoma Cells through a Mitogen Activated Protein Kinase (MAPK)-dependent Pathway
	Taejin J Song, Prasad S Adusumilli, MD, Yuman Fong, MD, Ansan Hospital, Korea University Medical Center, Ansan, Republic of Korea; Memorial Sloan-Kettering Cancer Center, New York, NY.
	Oral Posters (OP – 06) Liver II: Benign and Education/Outcomes
	Moderators: David Mahvi, MD, Madison, WI and Michele Molinari, MD, Halifax, NS

	Abstract Numbers 65 – 76
	65.) Liver, pancreas and biliary surgery, what is the right fellowship for the right training?
	Roozbeh Rassadi, MD, Richard M. Dickerman, MD, Ernest L. Dunn, MD, Dhiresh Rohan Jeyarajah, MD, Dallas Methodist Medical Center, Dallas, TX.
	66.) Outcomes of Hepatobiliary Surgery in a Community Hospital
	Austin Spitzer, MD, Ck Chang, MD, Pascal R Fuchshuber, UCSF-East Bay, Oakland, Ca 94602, CA; Kaiser Med. Center, Walnut Creek, CA.
	67.) Outcomes in Patients Undergoing Hepatic Resection in the Calgary Health Region Before and After the Creation of a Regional HPB Program.
	Elijah Dixon, MD, Andrew Mckay, MD, Paul Renfrew, MD, Oliver Bathe, MD, Francis Sutherland, MD, University of Calgary, Calgary, AB, Canada.
	68.) Laparoscopic Hepatic Cyst Marsupialization: A Review of Our Institutional Experience
	Siddhartha Rath, MD, Jeremy Timmer, MD, Kevin Neal Boykin, MD, Gazi B Zibari, MD, Louisiana State Health Sciences Center in Shreveport, Shreveport, LA.
	69.) Surgical Treatment of Hydatid Liver Disease
	Alexander R Karamarkovic, MD, PhD, University Center for Emergency Surgery, School of Medicine University of Belgrade, Belgrade, Serbia and Montenegro.
	70.) Resection of hepatic adenoma in patients with glycogen storage disease type Ia
	Srinevas K Reddy, MD, Dev M. Desai, MD, PhD, Priya S. Kishnani, MD, Bryan M. Clary, MD, Duke University Medical Center, Durham, NC.
	71.) Indication and long-term outcome of treatment for Focal Nodular Hyperplasia
	Glenn K Bonney, Dhanwant Gomez, Ahmad Al-mukhtar, Giles Toogood, J.peter Lodge, K. Rajendra Prasad, St James' University Hospital, Leeds, United Kingdom; St James' University Hospital, Leeds Ls9 7tf, United Kingdom.
	72.) Spontaneous Rupture and Hemorrhage of Focal Nodular Hyperplasia: A Case Report and Review of Literature
	Kerry Rodgers, MD, Rajan Chahal, MD, Randall S Zuckerman, MD, The Mary Imogene Bassett Hospital, Cooperstown, NY.
	73.) Spontaneous Hepatic Rupture
	Wai Gin Lee, MBBS, Jonathan Koea, MD, Auckland District Health Board, Auckland, New Zealand.
	74.) A New Technique For A Successful Management Of Suprahepatic Complete Caval Transection
	Ignazio R. Marino, MD, Fabrizio Di Francesco, MD, Cataldo Doria, MD, PhD, Salvatore Gruttadauria, MD, Augusto Lauro, MD, Victor L. Scott, Division of Transplantation, Department of Surgery, Jefferson Medical College, Philadelphia, PA; IsMeTT, Palermo, Italy; Centro Trapianti di Fegato e Multiorgano, University of Bologna, Bologna, Italy; Department of Anesthesiology, Maricopa Medical Center, Phoenix, AZ.
	75.) Intrahepatic portal venous variations: Demonstrations by 64-channel multidetector CT
	Dong-eun Park, MD, PhD, Kwon-mook Chae, MD, PhD, Wonkwang University Colledge of Medicine, Ikan, Korea, Republic of Korea.
	76.) Extrahepatic Portal Vein Aneurysm-Report of Six Cases and Review of Literature
	T. Clark Gamblin, MD, Sung Cho, MD, Alan Tsung, MD, Fady Balaa, MD, David A Geller, MD, Paulo Fontes, MD, Wallis Marsh, MD, UPMC Liver Cancer Center, University of Pittsburgh, Pittsburgh, PA.
	Oral Posters (OP – 07) Liver III: Techniques
	Moderators: Julie Stein, MD, Detroit, MI and Tim Sielaff, MD, Minneapolis, MN

	Abstract Numbers 77 – 88
	77.) Epidural Use is Associated with Increased Risk of Blood Transfusion Following Hepatic Resection
	Andrew Page, MD, Bradley Rostad, None, Keith Delman, MD, Charles Staley, MD, William Wood, MD, David Kooby, MD, Emory University, Atlanta, GA.
	78.) Comparison of Intraoperative Blood Salvage versus Conventional Methods to Lower Central Venous Pressure in Patients Undergoing Liver Resection for Primary and Secondary Hepatic Malignancies
	Cheng Chu, None, Sarah Bodin, MD, Gregory Pomper, MD, Thomas Mccoy, MS, Perry Shen, MD, Wake Forest School of Medicine, Winston-salem, NC.
	79.) Current Practice Of US Hepatic Surgeons-Results Of A Survey Of Surgical Technique.
	Majella Doyle, MD, Marcus C Tan, MD, Christopher D Anderson, MD, Steven M Strasberg, MD, William G Hawkins, MD, William C Chapman, MD, David C Linehan, MD, Washington University School of Medicine, St Louis, MO.
	80.) Factors Predicting Outcomes following Hepatic Resection in Livers with Abnormal Parenchyma
	Glenn K Bonney, Dhanwant Gomez, Alistair Young, Kirubakaran Ranganathan, Giles Toogood, Peter Lodge, K. Rajendra Prasad, St James' University Hospital, Leeds, United Kingdom; St James' University Hospital, Leeds Ls9 7tf, United Kingdom.
	81.) The Risk Of Gas Embolism During Laparoscopic Liver Resection Is Related To Parenchymal Transection Technique
	Gerry N. Polyhronopoulos, MD, Liane S. Feldman, MD, Anthony L. Mccluney, MD, Jean Buithieu, MD, John B. Martinie, MD, Peter Metrakos, Gerald M. Fried, MD, McGill University Health Centre, Montreal, PQ, Canada.
	82.) A Comparison of Stapled Transection versus Ligasure in Laparoscopic Liver Resection
	Reza Saidi, MD, Ahmed Ahad, MD, Rossini Escobar, I Nalbantoglu, MD, Volkan Adsay, MD, Michael J Jacobs, Providence Hospital and Medical Centers, Southfield, MI; Detroit Medical Center, Detroit, MI.
	83.) Lessons learned from 130 laparoscopic liver resections.
	Nicholas O'rourke, Les Nathanson, Ian Martin, George Fielding, George Hopkins, royal brisbane hospital, Auchenflower, Australia.
	84.) Mesohepatectomy as a safe alternative to extended hemihepatectomy in central liver tumors
	Zh. A. Mood, MD, A. Mehrabi, MD, PhD, N. Roshanaei, MD, J. Weitz, MD, PhD, M. W. Buechler, MD, PhD, J. Schmidt, MD, PhD, University of Heidelberg, Heidelberg, Germany.
	85.) Proliferative Activity of Liver Tumours Following Embolization of the Portal Vein
	Osama M Damrah, Nagy Habib, Long Jiao, Hammersmith Hospital-Imperial College London, London, United Kingdom.
	86.) Morbidity and Mortality Following Multi-Visceral Resections in Complex Hepatic and Pancreatic Surgery
	Andrew Mckay, MD, Oliver F. Bathe, MD, Francis R. Sutherland, MD, Elijah Dixon, MD, University of Calgary, Calgary, AB, Canada.
	87.) Liver autotransplantation according to a "modified orthotopic piggy-back" technique.
	L.Roveda*§, U.Prati*§, A.Puzziello*§#, G.Vescio*§#, B.DiVenere°, D.Timurian°, J.Bakeine°, A.Zonta, Laura Roveda, MD, Cancer Institute, University of Magna Graecia, Germaneto, Catanzaro, Italy.
	88.) Transcatheter Arterial Chemoembolization (TACE) for Breast Cancer Liver Metastasis: Single Institution Experience
	Sung Cho, MD, Fady K Balaa, MD, Jennifer Steel, PhD, Brian Carr, MD, PhD, T. Clark Gamblin, MD, UPMC Liver Cancer Center, University of Pittsburgh, Pittsburgh, PA.

3:30 – 3:55 p.m.	President's Invited Lecturer	(Pacific Ballroom)
	“Global Health: Challenges and Opportunities”
	Introduction:  Sean Mulvihill, MD, President, AHPBA, Salt Lake City, UT
	Speaker:  Haile Debas, MD, San Francisco, CA
4:00 – 4:25 p.m.	IHPBA Presidential Address	(Pacific Ballroom)
	Introduction: Henry Pitt, MD, Indianapolis, IN
	Evidence in HPB Surgery: We need large international trials!
	Markus Buechler, MD, Heidelberg, Germany
4:30 – 5:15 p.m.	ParallelDebates	(Las Vegas Rooms)
	“Regionalization of HPB Care? Good or Bad?”
	Moderators: Edward Whang, MD, Boston, MA and Leonidas Koniaris, MD, Miami, FL
	Pro: O. Joe Hines, MD, Los Angeles, CA
	Con: Thomas Howard, MD, Indianapolis, IN
4:30 – 5:15 p.m.	ParallelDebates	(Pacific Ballroom)
	“Hepatocellular Carcinoma: Transplant is Standard of Care versus Resection”
	Moderators: Will Chapman, MD, St. Louis, MO and Susan Orloff, MD, Portland, OR
	Pro: Jean Emond, MD, New York, NY
	Con: Myron Schwartz, MD, New York, NY
5:20 – 5:40 p.m.	Research Fellowship Presentation	(Pacific Ballroom)
	2005 Award Recipients
	Sunil Geevarghese, MD, Vanderbilt University Medical Center Ethicon HPB Physiology/Biology Award
	Title: The Role of Mitochondrial Calcium Management in Hepatic Ischemia-Reperfusion Injury
	Jon Dorfman, MD, Boston University Medical Center
	Sanofi Aventis HPB Oncology Award
	Positron Emission Tomography to Monitor HSV-1 Viral Oncolysis
	2006 Award Recipients
	Andres J. Vardanian, MD, University of California Los Angeles
	Ethicon HPB Physiology/Biology Award
	Title: The Role of Type 1 and Type 2 Interferons in Toll-like Receptor 4 Signal Transduction:
	Implications for Liver Ischemia-Reperfusion Injury
	Susan C. Pitt, MD, University of Wisconsin Madison
	Sanofi Aventis HPB Oncology Award
	Title: Signaling Pathways in Gastrointestinal Neuroendocrine Tumors
	Presiding – J. Nicolas Vauthey, MD, Houston, TX
	AHPBA Research/Education Chair
5:40 – 6:10 p.m.	Business Meeting	(Pacific Ballroom)
	Presiding – Sean Mulvihill, MD, President, AHPBA
6:15 – 7:00 p.m.	AHPBA Reception	(Paris Hotel)
7:00 – 11:30 p.m.	AHPBA-SAGES Joint Event	(Concorde Ballroom B, Paris Hotel)
	“A NIGHT AT THE MOVIES”

7:00 – 9:15 p.m.	AHPBA Competitive Videos
	Competitive Video (VD – 01) Liver
	Abstract Numbers 89–96
	89.) Liver Hydatid Cyst: Laparoscopic Treatment
	Martín Palavecino, MD, Mariano Bregante, MD, Diego Fernández, MD, Víctor Im, MD, Eduardo De Santibañes, Juan Pekolj, MD, Hospital Italiano, Buenos Aires, Argentina.
	90.) Small Diameter Prosthetic H-graft Portacaval Shunt
	Alexander Rosemurgy II, MD, Sam Al-saadi, MD, Desiree Villadolid, MPH, Rachel Gillman, Emily Kraemer, Sarah Cowgill, MD, University of South Florida and Tampa General Hospital, Tampa, FL.
	91.) Video: Bloodless open right hepatic lobectomy for metastatic colorectal cancer with the staple technique
	Allan Tsung, MD, Fady K Balaa, MD, T. Clark Gamblin, MD, David A Geller, MD, UPMC Liver Cancer Center, University of Pittsburgh, Pittsburgh, PA.
	92.) Hepatic Metastectomy Using a Four-Prong Radiofrequency Coagulation Device (Habib 4X, RITA Medical)
	Byrne Lee, MD, Lawrence D. Wagman, MD, City of Hope National Medical Center, Duarte, CA.
	93.) En bloc resection of the left colon, distal pancreas, spleen and simultaneous right hepatectomy for metastatic colon carcinoma by the laparscopic approach.
	Chandrakanth Are, Simonetta Iacovitti, MD, Guiseppe Mustacciouli, MD, Francesco M Crafa, MD, Ospedale Madre Guiseppina Vannini, Rome, Italy.
	94.) Laparoscopic Hepatic And Diaphragmatic Resection For The Treatment Of An Ovarian Tumor Implant
	Diego Fernández, MD, Martín Palavecino, MD, Christian Bertona, MD, Mariano Bregante, MD, Rodrigo Sánchez Clariá, MD, Oscar Mazza, MD, Eduardo De Santibañes, MS, Juan Pekolj, MD, Hospital Italiano, Buenos Aires, Argentina.
	95.) Right Hepatectomy with Cholecystectomy for Metastatic Colorectal Cancer
	Alexander Rosemurgy II, MD, Mallika Tarkas, Ashley Thomas, Desiree Villadolid, MPH, Donald Thometz, Sharona Ross, MD, Sarah M Cowgill, MD, University of South Florida and Tampa General Hospital, Tampa, FL.
	96.) Video: Laparoscopic left hepatic lobectomy for 12 cm HCC
	Fady K Balaa, MD, T Clark Gamblin, MD, David A Geller, MD, UPMC Liver Cancer Center, University of Pittsburgh, Pittsburgh, PA.
	Competitive Video (VD – 02)Pancreas/Biliary
	Abstract Numbers 97 – 104
	97.) Mirizzi's Syndrome: Laparoscopic Treatment
	Martín Palavecino, MD, Mariano Bregante, MD, Victoria Ardiles, MD, Diego Fernández, MD, Eduardo De Santibañes, Juan Pekolj, MD, PhD, Hospital Italiano, Buenos Aires, Argentina.
	98.) Intrahepatic Segment III Hepaticojejunostomy for Biliary Obstruction after Right Hepatectomy
	Richard A Mackey, MD, Conrad H Simpfendorfer, MD, J. Michael Henderson, MD, Cleveland Clinic Foundation, Cleveland, OH.
	99.) Laparoscopic treatment of Choledochal Cyst
	Sergio E Bustos (Maac), MD, Jorge Nefa (Maac), MD, Pablo Omelanczuk, MD, Walther Minatti (Maac), Mario Masrur, MD, Mariana Debé, MD, Italian Hospital of Mendoza, Mendoza, Argentina.
	100.) Laparoscopic Biliodigestive Anastomosis
	Mariano Bregante, MD, Martín Palavecino, MD, Diego Fernández, MD, Rodrigo Sánchez Clariá, MD, Eduardo De Santibañes, Juan Pekolj, MD, Hospital Italiano, Buenos Aires, Argentina.
	101.) Organ-Preserving Pancreatic Head Resection In Chronic Pancreatitis
	Gyula Farkas, MD, PhD, László Leindler, MD, Gyula Farkas Jr., MD, Department of Surgery, Faculty of Medicine, University of Szeged, Szeged, Hungary.
	102.) Biliary Peritonitis: Laparoscopic Treatment
	Diego Fernández, MD, Martín Palavecino, MD, Mariano Bregante, MD, Rodrigo Sánchez Clariá, MD, Eduardo De Santibañes, Juan Pekolj, MD, Hospital Italiano, Buenos Aires, Argentina.
	103.) Laparoscopic Distal Pancreatectomy and Splenectomy for Insulinoma
	Maki Yamamoto, MD, Michael S Hayashi, MD, Blanding U Jones, MD, Peter Lin, MD, Kaylene Anne Barrera, John G Lee, MD, Thang D Nguyen, MD, Ninh Nguyen, MD, David K Imagawa, MD, PhD, UC Irvine Medical Center, Orange, CA.
	104.) Complex Bile Duct Injury Treatment With A Right Hepatectomy And Hepaticojejunostomy
	Eduardo De Santibañes, MD, PhD, Martín Palavecino, MD, Diego Fernández, MD, Mariano Bregante, MD, Juan Pekolj, MD, PhD, Hospital Italiano, Buenos Aires, Argentina.
9:30 – 11:30 p.m.	“Rocky Horror Picture Show”
	SAGES Invited Videos
7:00 – 10:00 p.m.	AHPBA Presidential Dinner- (by invitation only)

Saturday, April 21^st, 2007: General Sessions

7:30 – 5:30 p.m.	Meeting Registration	(Lobby, Bally’ Hotel)
7:30 – 12:15 p.m.	Coffee Available	(Lobby, Bally's Hotel)
6:15 – 7:55 a.m.	Industry Sponsored Breakfast Symposium	(Las Vegas Rooms)
	Procedural Advances in Liver Resection using Endoscopic Stapling Techniques
	Joesph F. Buel, MD, Louisville, KY (sponsored by AutoSuture, United States Surgical, Tyco Healthcare)
	Reducing Blood Loss and Leak Rates in Hepatobiliary Surgery
	David A. Geller, MD, Pittsburgh, PA and Kevin Watkins, MD, Stony Brook, NY, (sponsored by TissueLink)
	Waterjet Dissection for Parenchymal Division during Hepatectomy—the Toronto Experience
	Paul Greig, MD, Toronto, ON, (sponsored by ERBE USA, Inc.)
	Minimally Invasive Liver Surgery
	T. Clark Gamblin, MD, Pittsburgh, PA, (sponsored by Aloka)

8:00 – 9:55 a.m.	Symposium
	Current Management of Hepatic Colorectal Metastasis	(Pacific Ballroom)
	Moderators: Elijah Dixon, MD,Calgary, AB and Roderich Schwarz, MD, New Brunswick, NJ
	Introduction and Case Presentation
	Speakers: Mike D'Angelica, MD, New York, NY
	Patient Selection: Anatomic and Clinical Risk Scoring Considerations
	David Linehan, MD, St. Louis, MO
	Radiology for the Surgeon and the Role of Pet Scanning
	Eddie Abdalla, MD, Houston, TX
	Problems of Preoperative Chemotherapy: In Whom? What Agents? For how long? What should be removed in responders?
	Alice Wei, MD, Toronto, ON
	Extending Resectability: PVE and Two Stage Resections
	William Jarnagin, MD, New York, NY
	Extending Resectability: The Role of Ablation
	Eduardo de Santibañes, MD, Buenos Aires, Argentina
	The Management of Synchronous Lesions
	Panel Discussion of Cases and Audience Questions

8:00 – 9:55 a.m.	ParallelFree Papers Session: Pancreas Benign	(Las Vegas Rooms)
	Free Papers (FP – 01) Pancreas: Benign
	Abstract Numbers 105 – 112
	105.) Systematic appraisal of biochemical markers for assessment of disease severity in acute pancreatitis:guidance for evidence-based practice in 2007.
	Benoy I Babu, MBBS, Ajith K Siriwardena, MD, HPB Unit, Dept of Surgery, Manchester Royal Infirmary, Manchester, United Kingdom.
	106.) The Logistic Organ Dysfunction Score-Modified Atlanta Categorization Permits Precise Prognostication And Allocation Of Severity In Acute Pancreatitis.
	Srinivasan Balachandra, MBBS, James M Mason, PhD, Anil Bagul, MBBS, Ajith K Siriwardena, HPB Unit, Dept of Surgery, Manchester Royal Infirmary, Manchester, United Kingdom; School for Health, University of Durham, Stockton-on-tees, United Kingdom.
	107.) Pancreatic Pseudocysts: Is Delayed Surgical Intervention Associated With Adverse Outcomes?
	Kaori Ito, MD, Michael Abramson, MD, Alexander Perez, MD, Hiromichi Ito, MD, Amarsanaa Jazag, MD, PhD, Jill Van Der Zee, MD, Edward E Whang, MD, Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
	108.) Long-Term Follow-Up After Organ-Preserving Pancreatic Head Resection In Patients With Chronic Pancreatitis
	Gyula Farkas, MD, PhD, László Leindler, MD, Attila Paszt, MD, Mária Daróczi, MD, Gyula Farkas Jr., MD, Department of Surgery, Faculty of Medicine, University of Szeged, Szeged, Hungary.
	109.) Surgical Treatment Of Alcohol-induced Chronic Pancreatitis: The Challenges and Pitfalls
	Thomas Schnelldorfer, MD, David B. Adams, MD, Medical University of South Carolina, Charleston, SC.
	110.) Predictive Risk Factors for Development of Pancreatic Fistula Utilizing the ISGPF Classification Scheme
	Wande Pratt, Mark Callery, MD, Charles Vollmer, MD, Beth Israel Deaconess Medical Center, Boston, MA.
	111.) Pancreatic Leak Rates After Distal Pancreatectomy Using the International Grading System (ISGPF)
	Thien Khai Nguyen, MD, L. William Traverso, MD, Virginia Mason Medical Center, Seattle, WA.
	112.) Effect of Bioglue on the Incidence of Pancreatic Fistula Following Pancreas Resection
	William E. Fisher, MD, Christy Chai, MD, Sally E. Hodges, Meng-fen Wu, MS, Susan G. Hilsenbeck, PhD, F. Charles Brunicardi, MD, Baylor College of Medicine, Houston, TX.

8:00 – 9:55 a.m.	ParallelFree Papers Session: Biliary I	(Las Vegas)
	Free Papers (FP – 02) Biliary I
	Abstract Numbers 113 – 120
	113.) Pancreaticobiliary maljunction with non-dilated bile duct is an extreme high risk group of biliary tract cancers: Analysis of a nation wide registry of pancreatico-biliary maljunction in Japan.
	Mitsuo Shimada, MD, Teruyoshi Amagai, MD, Toshihide Imaizumi, MD, Hiroshi Shimada, MD, Hideo Takamatsu, MD, Akira Toki, MD, Toshinobu Matsumura, MD, Shuichi Miyakawa, MD, Yuji Morine, MD, Japanese Study group on Pancreaticobiliary Maljunction, The University of Tokushima, Tokushima, Japan; Committee for Registration of the Japanese Study group on Pancreaticobiliary Maljunction, Tokushima, Japan.
	114.) Loss of FHIT Expression in Pancreatobiliary Cancers
	Mark Bloomston, MD, Jeffrey Kneile, MD, Osama Al-saif, MBBS, Peter Muscarella II, MD, E. Christopher Ellison, MD, Wendy L Frankel, MD, Ohio State University, Columbus, OH.
	115.) The role of thymidylate synthase (TS) and dihydropyrimidine dehydrogenase (DPD) expression in biliary tract carcinoma
	Yuji Morine, MD, PhD, Satoru Imura, MD, PhD, Tetsuya Ikemoto, MD, PhD, Kotaro Miyake, MD, PhD, Hiroki Mori, MD, Yusuke Arakawa, MD, Mami Kanamoto, MD, Kozo Yoshikawa, MD, Tomoharu Yoshizumi, MD, PhD, Mitsuo Shimada, MD, PhD, Department of Surgery, University of Tokushima, Japan, Tokushima, Japan.
	116.) Intrahepatic Cholangiocarcinomas: Treatment Characteristics and Results
	Roderich E Schwarz, MD, PhD, David D. Smith, PhD, UMDNJ-RWJMS, New Brunswick, NJ; City of Hope Cancer Center, Duarte, CA.
	117.) Evolving Incidence and Outcomes for Cholangiocarcinoma in the U.S.: Analysis of 7,410 Cases
	William E Sumner III, MD, Juan C Gutierrez, MD, Dido Franceschi, MD, Alan S Livingstone, MD, Leonidas G Koniaris, MD, University of Miami, Miami, FL.
	118.) Germline APC and MYH Mutations do not Account for a Significant Fraction of Sporadic Ampullary Cancer
	George Zogopoulos, MD, PhD, Zane Gallinger, Robin Kim, MD, Ian D. Mcgilvray, MD, PhD, Alice Wei, MD, Bryce Taylor, MD, Bernard Langer, MD, Paul Greig, MD, Richard Hart, MD, Runjan Runjan Chetty, MD, Steven Gallinger, MD, University of Toronto, Toronto, ON, Canada.
	119.) Estrogen Receptorα, Estrogen receptorβ and Progesteron receptor as a possible prognostic factor in radically resected primary gallbladder carcinoma
	Dong-sup Yoon, MD, PhD, Joon Seong Park, MD, Kyung-sik Kim, MD, PhD, Jin-sup Choi, MD, Woo-jung Lee, MD, Hoon-sang Chi, MD, PhD, Yonsei University Medical College, Seoul, Republic of Korea.
	120.) Long term follow-up of Mexican patients with Gallbladder Cancer
	Ricardo Joaquin Mondragón-sanchez 80, MD, PhD, Elvira Gómez-gómez 2003, MD, Alicia Ivette López-estrada 2006, Ofelia Arias-arias 2005, Rodrigo Jasso-barranco 2006, MD, Brenda Elena Aguilar-álvarez 5006, MD, issemym, Toluca, Mexico.

8:00 – 9:55 a.m.	ParallelFree Papers Session:Pancreas Malignant	(Las Vegas Rooms)
	Free Papers (FP – 03) Pancreas: Malignant
	Abstract Numbers 121 – 128
	121.) Diagnostic laparoscopy for patients with potentially resectable pancreatic adenocarcinoma: Is it cost effective in the current era?
	C. Kristian Enestvedt, MD, Skye C Mayo, MD, MPH, Brian Diggs, PhD, Tomi Mori, PhD, Donald Austin, MD, MPH, Donald K Shipley, MS, Brett Sheppard, MD, Kevin G Billingsley, MD, Oregon Health and Science University, Portland, OR; Johns Hopkins Hospital, Baltimore, MD; Oregon State Cancer Registry, Portland, OR.
	122.) How useful are clinical, biochemical and cross-sectional imaging features in predicting premalignant or malignant cystic lesions of the pancreas?
	Brian K Goh, MBBS, Yu-meng Tan, Choon-hua Thng, MBBS, Peng-chung Cheow, MBBS, Yaw-fui Chung, MBBS, Pierce K. H. Chow, PhD, Wai-keong Wong, MBBS, London Lucien Ooi, MD, Singapore General Hospital, Singapore, Singapore.
	123.) Characteristics of Malignancy in Intraductal Papillary Mucinous Neoplasms
	Jayme B. Stokes, MD, Edward B. Stelow, MD, Marc Sarti, MD, Eduard E. De Lange, MD, Christopher A. Moskaluk, MD, PhD, Reid B. Adams, MD, Todd W. Bauer, MD, University of Virginia, Charlottesville, VA.
	124.) Pancreatic Adenocarcinoma: the actual 5yr survivors
	Cristina R Ferrone, MD, Peter J Allen, MD, Daniel G Coit, MD, Sun Chung, MD, Laura Tang, MD, David Klimstra, MD, Murray F Brennan, MD, Massachusetts General Hospital, Boston, MA; Memorial Sloan Kettering Cancer Center, New York, NY; New York Hospital, New York, NY.
	125.) Adjuvant Chemotherapy Is Associated To Good Survival In Patients Underwent Extended Pancreaticoduodenectomy For Pancreatic Cancer.
	Calogero Iacono, MD, Maurizio Cantore, Andrea Ruzzenente, MD, Giuseppe Verlato, Enrico Facci, Tommaso Campagnaro, Andrea Mambrini, Silvia Pachera, Alfredo Guglielmi, University of Verona, Verona, Italy; Dept of Oncology, Massa Carrara, Italy.
	126.) Neoadjuvant Chemotherapy and Radiation for Patients with Locally Unresectable Pancreatic Adenocarcinoma: Safety, Efficacy and Survival
	John D Allendorf, Margaret Lauerman, Aliye Bill, Mary Digiorgi, Nichole Goetz, Beth Schrope, William Sherman, Robert Fine, John Chabot, Columbia University, New York, NY.
	127.) Management Of Delayed Arterial Haemorrhage After Pancreaticoduodenectomy- A Meta-Analysis
	Madhava Pai, Paolo Limongelli, Andrew Healey, Osama Damrah, James Jackson, Robin Williamson, Long Jiao, Hammersmith Hospital, Imperial College,, London, United Kingdom.
	128.) Resection for metastatic pancreatic carcinoid tumors improves survival
	Jensen C. C. Tan, MD, Anand Govindarajan, MD, Natalie G. Coburn, MD, Sherif Hanna, MD, Calvin H. L. Law, MD, University of Toronto, Toronto, ON, Canada.
10:00 – 10:25 a.m.	State of the Art Address	(Pacific Ballroom)
	“Pancreatic Cystic Neoplasms”
	Speaker: Mark Callery, MD, Boston, MA

10:00 – 12:15 p.m.	ParallelFree Papers Session: Basic Science	(Las Vegas Rooms)
	Free Papers (FP – 04) Basic Science
	Abstract Numbers 129 – 139
	129.) Tumor lysate-pulsed dendritic cells confer protective immunity in a murine pancreatic cancer model
	Nasreen A. Vohra, MD, Shari Pilon-thomas, PhD, James J Mulé, PhD, Emmanuel E. Zervos, MD, University of South Florida College of Medicine, Tampa, FL; H. Lee Moffitt Cancer Center, Tampa, FL.
	130.) Liver Specific Tolerance to a Tumor Associated Antigen
	Eric Kimchi, MD, Olivier Rolin, Diego Avella, MD, Luis Garcia, MD, Kevin Staveley-o'carroll, MD, PhD, Penn State University, Hershey, PA.
	131.) Enhancing Gemcitabine-mediated Effects against Experimental Pancreatic Cancer via two Antiangiogenic Strategies
	Roderich E Schwarz, MD, PhD, Srivani Konduri, PhD, Niranjan Awasthi, PhD, Danielle Cafasso, Lauren Caldwell, Margaret A Schwarz, MD, UMDNJ-RWJMS, New Brunswick, NJ.
	132.) A Novel Suicide Gene Therapy Regimen Targeting the Overexpression of Eukaryotic Initiation Factor 4E in a Pancreatic Cancer Cell Line
	Kerry W Byrnes, MD, Neal Holm, MD, Bradford Siegele, MS, Benjamin Li, MD, Michael Mathis, PhD, Yoshi Odaka, PhD, Quyen Chu, MD, LSU Health Sciences Center, Shreveport, LA.
	133.) Proliferative biliary epithelia are the major contributor to high levels of hepatic CD44 expressed by cholestatic livers
	Yao He, MD, PhD, Gordon D Wu, MD, Jan Li, PhD, Tomohito Sadahiro, MD, PhD, Hui Zhu, MD, PhD, Sangik Noh, MD, Andrew S Klein, MD, Cedars-Sinai Medical Center, Los Angeles, CA.
	134.) Disruption of transforming growth factor-β signaling through β-spectrin ELF leads to early hepatocarcinogenesis through overexpression of cyclin D1
	Krit Kitisin, MD, Natarajan Ganesan, PhD, Eugene A Volpe, PhD, Sang Soo Kim, PhD, Varalakshmi Katuri, PhD, Wilma Jogunoori, PhD, Jon Mendelson, MS, Bibhutibhushan Mishra, MD, Lopa Mishra, MD, Lynt B Johnson, MD, Georgetown University, Washington, DC.
	135.) The Emerging Role of NK-kB in Hepatitis C-Associated Hepatocellular Tumorigenesis
	Amanda Cooper, MD, Jian-min Wu, PhD, Poornima Nakshatri, MS, Harikrishna Nakshatri, PhD, Mary Maluccio, MD, MPH, Indiana University School of Medicine, Indianapolis, IN.
	136.) Increased Endotoxin Translocation in obesity: a cause of steatotic liver damage
	Justin D Ellett, Zachary P Evans, Matthew Crumpler, Kenneth D Chavin, MD, PhD, Medical University of South Carolina, Charleston, SC.
	137.) Remote ischemic preconditioning modulates hepatic microcirculation through the hemeoxygenase pathway in a rat model of warm ischemia reperfusion injury of the liver.
	Niteen Tapuria, MS, Sameer Junnarkar, MS, Barry Fuller, PhD, Alexander M Seifalian, PhD, Brian R Davidson, MD, Neelanjana Dutta, MD, Royal Free Hospital, London, United Kingdom; Kings college Hospital, London, United Kingdom.
	138.) Increased activation of proapoptotic genes in old vs young livers following ischemia and reperfusion- A new mechanism of injury
	Markus Selzner, MD, Nazia Selzner, MD, PhD, Limin Chen, PhD, Ivan Borozan, PhD, Jing Sun, PhD, Ian Mcgilvray, MD, PhD, Toronto General Hospital, Toronto, ON, Canada.
	139.) Uncoupling Protein-2 Promotes Hepatocyte Death in a Model of In Vitro Steatosis and Hypoxia/Reoxygenation
	Zachary P Evans, William N Toussaint, Justin D Ellett, Kenneth D Chavin, MD, PhD, Medical University of South Carolina, Charleston, SC.

10:00 – 12:00 p.m.	ParallelFree Papers Session: Transplant	(Las Vegas Rooms)
	Free Papers (FP – 05) Transplant
	Abstract Number 140 – 149
	140.) Role of primary resection for HCC under the era of liver transplantation
	Toshiya Kamiyama, Kazuaki Nakanishi, MD, PhD, Hirofumi Kamachi, MD, PhD, Hideki Yokoo, MD, PhD, Munenori Tahara, MD, PhD, Hirofumi Toi, MD, PhD, Kenichiro Yamashita, MD, PhD, Masahiko Taniguchi, MD, PhD, Tomomi Suzuki, MD, PhD, Tsuyoshi Shimamura, MD, PhD, Hiroyuki Furukawa, MD, PhD, Michiaki Matsushita, MD, PhD, Satoru Todo, MD, PhD, Hokkaido University, Sapporo, Japan.
	141.) Improved Survival in Hepatocellular Carcinoma: Results of a Single Center Analysis of 501 Patients
	David Kooby, MD, Vasili Egnatashvili, MD, Michael Graiser, PhD, Keith Delman, MD, William Wood, MD, Charles Staley, MD, Emory University, Atlanta, GA.
	142.) Tumor Size and Meld Score Predict Microvascular Invasion in Cirrhotic Patients with Hepatocellular Carcinoma
	Swee H Teh, MD, B C Sheppard, MD, J Schwartz, MD, K G Billingsley, MD, S Cha, PhD, P S Kamath, MD, S L Orloff, MD, D M Nagorney, MD, Depart of Surgery, Oregon Health Sciences University, Portland, OR; Mayo Clinic, Rochester, MN.
	143.) Outcomes Analysis for 280 Patients with Cholangiocarcinoma Treated with Liver Transplantation Over an 18-year Period
	Natasha S Becker, MD, Joel Rodriguez, MD, Neal R Barshes, MD, MPH, Christine O'mahony, MD, John A Goss, MD, Thomas A Aloia, MD, Baylor College of Medicine, Houston, TX.
	144.) Utilization of HTLV Positive Donor Livers For Transplantation
	James V Guarrera, MD, Barbara Alkofer, MD, Jean C. Emond, MD, John F. Renz, MD, PhD, Columbia University, New York, NY.
	145.) Liver Transplantation In Latin America
	Eduardo De Santibañes, MD, PhD, Martín Palavecino, MD, Diego Fernández, MD, Victoria Ardiles, MD, Juan Mattera, MD, Juan Pekolj, MD, PhD, Miguel Ciardullo, MD, Hospital Italiano, Buenos Aires, Argentina.
	146.) How to Balance the Risk for a Living Liver Donor-Or Is Death Always Preventable?
	Burckhardt Ringe, MD, PhD, Humberto Soriano, MD, Ralph Petrucci, MD, William Meyers, MD, Drexel University College of Medicine, Philadelphia, PA.
	147.) Laparoscopically-Assisted Right Lobe Donor Hepatectomy: Results and Comparison with Open Lobe Donor Hepatectomy
	Alan J Koffron, MD, Robert Kung, Greg Auffenberg, Michael Abecassis, MD, Northwestern University Medical School, Chicago, IL.
	148.) Venous reconstruction in living-donor hepatectomy
	Atsushi Shimizu, MD, Yoshikazu Yasuda, MD, Masanobu Hyodo, MD, Taketo Fujiwara, MD, Yasunaru Sakuma, MD, Keisuke Yamashita, MD, Nobuyuki Hojo, MD, Hideo Chiba, MD, Makoto Ota, MD, Yoshito Nihei, MD, Hideo Nagai, MD, Jichi Medical School, Tochigi, Japan.
	149.) The effects of physical quality of life, time, and gender on change in symptoms of anxiety and depression after liver transplantation
	Robert T. Russell, MD, Irene D. Feurer, PhD, Panarut Wisawatapnimit, C. Wright Pinson, MD, MBA, Vanderbilt University Medical Center, Nashville, TN.

10:30 – 10:55 a.m.	State of the Art Address	(Pacific Ballroom)
	“Cytoreductive Hepatic Surgery – Integral Therapy for Metastatic Neuroendocrine Cancers”
	Speaker: David Nagorney, MD, Rochester, MN
11:00 – 12:15 p.m.	AHPBA / SAGES Joint Symposium	(Pacific Ballroom)
	Evaluation of Pancreatic Neoplasms
	Moderator: Sherry Wren MD, Palo Alto, CA
	Speakers: Eduard De Lange, MD, Charlottesville, VA
	Cross Sectional Imaging of the Pancreas: MRI
	Roy Soetikno, MD, Palo Alto, CA
	Endoscopic Ultrasonography
	Junji Machi, MD, Honolulu, HI
	Intraoperative Ultrasonography
	David Rattner, MD, Boston, MA
	Diagnostic Laparoscopy
	Case Based Discussion Panel: Pancreatic IncidentalomaFaculty & Audience
12:05 – 12:30 p.m.	State of the Art Address:	(Las Vegas Rooms)
	“Live Donor Adult Liver Transplantation: Donor and Recipient Outcomes”
	Speaker: Elizabeth Pomfret, MD, Burlington, MA
12:20 – 12:30 p.m.	NSABP C-09 Update	(Pacific Ballroom)
	Speaker: Lawrence Wagman, MD, Duarte, CA
12:30 – 2:00 p.m.	Lunch and Exhibit Viewing	(Paris Hotel)
2:00 – 4:10 p.m.	Symposium
	Total Pancreatectomy
	Moderators: Diane Simeone, MD, Ann Arbor, MI and Charles Vollmer, MD, Boston, MA
	I. Potential Indications for Total Pancreatectomy
	Speakers: Steve Gallinger, MD, Tornoto, ON
	Hereditary Pancreatic Cancer
	Keith Lillemoe, MD, Indianapolis, IN
	Intraductal Papillary Mucinous Neoplasm
	Andy Lowy, MD, Cincinnati, OH
	Chronic Pancreatitis
	Discussion – Faculty and Audience
	II. Techniques and Outcomes
	Speakers: Steve Strasberg, MD, St. Louis, MO
	Technical Considerations
	Chuck Burant, MD, Ann Arbor, MI
	Metabolic Sequelae of Total Pancreatectomy
	Syed Ahmad, MD, Cincinnati, OH
	Role of lslet Transplantation
	Dave Bigam, MD, Edmondton, AB
	Role of Pancreatic Transplantation
	Discussion – Faculty and Audience

2:00 – 4:10 p.m.	ParallelFree Papers Session: Liver	(Las Vegas Rooms)
	Free Papers (FP – 06) Liver I
	Abstract Numbers 150 – 157
	150.) Impact of Local Therapy for Hepatocellular Carcinoma on Survival Outcomes in the U.S. Population
	Roderich E Schwarz, MD, PhD, David D. Smith, PhD, UMDNJ-RWJMS, New Brunswick, NJ; City of Hope Cancer Center, Duarte, CA.
	151.) A Comparative Analysis of Selective Internal Radiation Therapy (SIRT) and Transcatheter Arterial Chemoembolization (TACE) in Treatment of Unresectable Hepatocellular Carcinoma
	Vasili Egnatashvili, MD, Abbas Chamsuddin, MD, Maksym Yezhelyev, MD, Keith Delman, MD, Charles Staley, MD, David Kooby, MD, Emory University, Atlanta, GA.
	152.) Hepatic Epithelioid Hemangioendothelioma: A Multi-Institutional Study of Treatment and Long Term Outcome
	Eugene A. Choi, MD, Jan Lerut, MD, Ricardo J. Gonzalez, MD, Steven A. Curley, MD, Jean N. Vauthey, MD, Peter W. Pisters, MD, Eddie K Abdalla, MD, University of Texas M. D. Anderson Cancer Center, Houston, TX; Saint-Luc University Clinics, Universite Catholique de Louvain, 1200 Brussels, Belgium.
	153.) Beneficial effect of Elaspol (sivelestat sodium hydrate) after Major Hepatectomy using Intermittent Pringle Maneuver in Swine.
	Mitsugi Shimoda, Yoshimi Iwasaki, MD, PhD, Tokihiko Sawada, MD, PhD, Keiichi Kubota, MD, PhD, Dokkyo Univ, School of Med., Mibu, Tochigi, Japan.
	154.) Evaluation of an Autologuous Fibrin Sealant in Patients Undergoing Liver Resections: A Multicenter Randomized Clinical Trial
	Dido Franceschi, MD, Alan Livingstone, MD, Michael Choti, MD, Ronald W Busuttil, MD, PhD, Michael D'angelica, MD, Linda S. Sher, MD, Trista Madsen, RN, BSN, Vijay Kumar, PhD, University of Miami, Miami, FL; Johns Hopkins Hospital, Baltimore, MD; UCLA, Los Angeles, CA; Memorial Sloan Kettering Cancer Center, New York, NY; USC, Los Angeles, CA; Thermogenesis, Rancho Cordova, CA.
	155.) Guidelines For Power And Time Variables For Microwave Ablation In A Porcine Liver
	William W. Hope, MD, Thomas M. Schmelzer, MD, William L. Newcomb, MD, Jessica J. Heath, Amy L. Lincourt, PhD, H. James Norton, PhD, B. Todd Heniford, MD, David A Iannitti, MD, Carolinas Medical Center, Charlotte, NC.
	156.) Right Hepatic Trisectionectomy-Analysis of a Single Centre Experience of Two Hundred and Seventy Five Cases.
	Karim J Halazun, Ahmed Al-mukhtar, Amer Aldoori, Hassan Malik, Moh'd Abu Al-hilal, Magdy S Attia, Shahid Farid, K Rajendra Prasad, Giles J Toogood, J Peter A Lodge, St. James' University Hospital, Leeds UK, Leeds, United Kingdom.
	157.) Right portal vein ligation is as efficient as portal vein embolization to induce hypertrophy of the left liver remnant.
	Beatrice Aussilhou, MD, Mickael Lesurtel, MD, Safi Dokmak, MD, Reza Kianmanesh, MD, Olivier Farges, MD, PhD, Alain Sauvanet, MD, Annie Sibert, MD, Valérie Vilgrain, MD, Jacques Belghiti, MD, Beaujon Hospital, Clichy, France.

2:00-4:10 p.m.

ParallelFree Papers Session: Education/Outcomes

(Las Vegas)

	Free Papers (FP – 07) Education / Outcomes
	Abstract Numbers 158 – 167
	158.) The Challenges of Resident Training in Complex Hepatic, Pancreatic, and Biliary Procedures
	Thomas S Helling, MD, Anjay K Khandelwal, MD, CONEMAUGH MEMORIAL MEDICAL CENTER, Johnstown, PA.
	159.) Umbilical Hernia Repair in the Presence of Cirrhosis and Ascites: Results of a Survey and a Review of the Literature.
	Andrew Mckay, MD, Oliver F. Bathe, MD, Elijah Dixon, MD, Francis R. Sutherland, MD, University of Calgary, Calgary, AB, Canada.
	160.) Surgical Treatment of Primary Hepatic Malignancy in the United States
	Joshua S Hill, MD, James T. Mcphee, MD, Giles F. Whalen, MD, Mary E Sullivan, MS, Frederick A Anderson, PhD, Jennifer F Tseng, MD, University of Massachusetts, Worcester, MA.
	161.) A Systematic Review on the Efficacy of Repeat Hepatectomy for Recurrent Liver Metastases from Colorectal Carcinoma
	Junyang Sim, Tristan Yan, Rui Niu, David Morris, St. George Hospital, Sydney, Australia.
	162.) Factors Influencing Perioperative Blood Transfusions in Patients Undergoing Major HPB procedures
	Varun Verma, None, Roderich E Schwarz, MD, PhD, UMDNJ-RWJMS, New Brunswick, NJ.
	163.) Morbidity, Mortality and Risk Factors in Distal and Subtotal Pancreatic Resections for Pancreatic Neoplasia: An Analysis of the National Surgical Quality Improvement Program
	H H Jackson, MD, T L Schifftner, S F Khuri, MD, W F Henderson, PhD, L Neumayer, MD, S J Mulvihill, MD, R E Glasgow, MD, University of Utah, Salt Lake City, UT; Colorado VAMC, Aurora, CO; West Roxbury VAMC, West Roxbury, MA.
	164.) Population based study of management of pancreatic adenocarcinoma
	S M Ashamalla, A Eppel, H Rothenmund, R Bromberg, D R Urbach, M J Moore, M Cotterchio, S Gallinger, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, ON, Canada.
	165.) Frequency with Which Surgeons Undertake Pancreaticoduodenectomy Continues to Determine Length of Stay, Hospital Charges, and In-hospital Mortality
	Alexander Rosemurgy, MD, Sarah M Cowgill, MD, Brian Coe, Sam Al-saadi, MD, Ashley Thomas, Jennifer Cooper, Sharona Ross, MD, Steven Goldin, MD, PhD, Emmanuel Zervos, MD, University Of South Florida And Tampa General Hospital, Tampa, FL.
	166.) Importance of Lymph Node Sampling in Staging of Periampullary Malignancies
	Juan C Gutierrez, MD, Alan S Livingstone, MD, Leonidas G Koniaris, MD, University of Miami Miller School of Medicine, Miami, FL.
	167.) The impact of extended lymph node dissection on the surgical resection of pancreatic head adenocarcinoma
	Joseph A Greco III, MD, Eric T Castaldo, MD, Alexander A Parikh, MD, Nipun B Merchant, MD, Vanderbilt University, Nashville, TN.

4:15 – 6:15 p.m.

Oral Poster Session

(Pacific Ballroom)

	Oral Posters II (OP – 08) Transplantation II
	Moderators: Ernesto Molmenti, MD, Tucson, AZ and Ken Chavin, MD, Charleston, SC
	Abstract Numbers 168 – 177
	168.) Budd-Chiari syndrome report of 3 unique cases and review of the literature.
	Juan M Palma-vargas, MD, Jorge A Ortiz, MD, Helen L Goldberg, MD, Kenneth Lazarus, MD, Francis Wright, MD, Preston Foster, MD, Texas Transplant institute, San Antonio, TX.
	169.) Laparoscopic Incisional Hernia Repair After Liver Transplantation
	Kristin L Mekeel, MD, Kunam S. Reddy, MD, Adyr H. Moss, MD, David C. Mulligan, MD, Kristi L. Harold, MD, Mayo Clinic, Phoenix, AZ.
	170.) Changing Contraindications to Liver Transplantation with Improved Survival: Obesity, Age >65 and Malignancy
	Lynt B Johnson, MD, MBA, Kirti Shetty, MD, Amy D Lu, Georgetown Univ Hospital, Washington, DC.
	171.) Will Liver Transplant for Hepatocellular Cancer using the UCSF criteria help?
	Linda L Wong, MD, University of Hawaii School of Medicine, Honolulu, HI.
	172.) Middle hepatic vein of the recipient as drainage for anterior sector veins (Segments V-VIII) in adult-to-adult Living Donor Liver Transplantation. (LDLT)
	Manuel I Rodriguez-davalos, Juan Pablo Rocca, MD, Michael Marvin, MD, Patricia A Sheiner, MD, Marcelo E Facciuto, MD, New York Medical College, Hawthorne, NY; New York Medical College, Tarrytown, NY.
	173.) Intraoperative Placement Of An Expandable Metallic Stent For A Portal Vein Trombosis After Living Donor Liver Transplantation
	Diego Fernández, MD, Martín Palavecino, MD, Juan Salceda, MD, Juan Mattera, MD, Juan Pekolj, MD, Miguel Ciardullo, MD, Eduardo De Santibañes, MD, PhD, Hospital Italiano, Buenos Aires, Argentina.
	174.) Reassessing the impact of perioperative blood transfusions on outcomes of liver transplantation
	Markus Selzner, MD, Huang Zhang, MD, Nazia Selzner, MD, PhD, Paul Greig, MD, Mark Cattral, MD, David Grant, MD, Stuart Mccluskey, MD, Ian Mcgilvray, MD, PhD, Toronto General Hospital, Toronto, ON, Canada.
	175.) Choledochoduodenostomy Offers An Alternative Biliary Reconstruction To Choledochojejunostomy In Liver Transplantation
	William Bennet, MD, PhD, Michael Zimmermann, MD, Michael Wachs, MD, Tom Bak, MD, Igal Kam, MD, University of Colorado Health and Science Center, Denver, CO.
	176.) Outcome of Biliary Stricture after right Living Donor Liver Transplant
	A. Gangemi, MD, U. Bareato, MD, A. C. Owens, MD, J. Bui, MD, D. West, MD, M. Porubsky, MD, J. Oberholzer, MD, Enrico Benedetti, MD, G. Testa, MD, University of Illinois at Chicago, Chicago, IL; University of Chicago, Chicago, IL.
	177.) Predictors of Biliary Complications Following Living Donor Liver Transplantation.
	Timothy Michael Schmitt, MD, David Kashmer, MD, Timothy L Pruett, MD, University of Virginia, Charlottesville, VA.
	Oral Posters II (OP – 09) Biliary II: Benign and Pancreatitis
	Moderators: Ketan Sheth, MD, Boston, MA and Dan Deizel, MD, Chicago, IL
	Abstract Numbers 178 – 188
	178.) Longitudinal duodenotomy for excision of benign duodenal neoplasms
	B Dillard, J Hering, S Garrean, J Espat, UIC, Chicago, IL.
	179.) DIC-CT and intra-operative cholangiography for laparoscopic cholecystectomy
	Jun-ichi Tanaka, MD, PhD, Yoshio Deguchi, MD, PhD, Shin-ei Kudo, MD, PhD, Showa University Northern Yokohama Hospital, Yokohama, Japan.
	180.) Laparoscopic cholecystectomy in Progressive Systemic Sclerosis
	Nihar R Dash, Devendra Gupta, MD, Rajan Saxena, MS, AIIMS,New Delhi,India, New Delhi, India; SGPGIMs,Lucknow, Lucknow, India.
	181.) New Approaches for Bloodless Laparoscopic Cholecystectomy in the Cirrhotic Patient
	Geetha Jeyabalan, MD, T. Clark Gamblin, MD, Fady Balaa, MD, David A Geller, MD, UPMC Liver Cancer Center, University of Pittsburgh, Pittsburgh, PA.
	182.) Hemoconcentration As An Early Marker Of Severity In The Acute Biliary Pancreatitis
	Alberto Fersini, MD, Tiziano Pio Valentino, MD, Caterina Santacroce, MD, Nicola Tartaglia, MD, Antonio Ambrosi, MD, Vincenzo Neri, MD, University of Foggia, Foggia, Italy.
	183.) Refractomery Role for Diagnosis of Pathologic Process in Acute Pancreatitis
	Valentina Lisienko, Edvard Mikaelyan, Urals State Medical Academy, Ekaterinburg, Russian Federation.
	184.) Minimally Invasive Procedures For The Treatment Of Acute Pancreatic Pseudocysts
	Oscar Mazza, MD, Martín Palavecino, MD, Diego Fernández, MD, Ricardo Mentz, MD, Juan Pekolj, MD, Eduardo De Santibañes, Hospital Italiano, Buenos Aires, Argentina.
	185.) Adult Congenital Choledochal Cyst
	Ricardo Joaquin Mondragón-sánchez, MD, FRCP, Elizabeth Aguilar-alaniz 2003, MD, Alejandro Mondragón-sánchez 80, MD, Yisvanth Pérez-ponce 80, MD, issemym, Toluca, Mexico.
	186.) Treatment of benign biliary stenosis with temporary self-expandable metallic stent
	Maryléne Plasse, MD, Franck Vandenbroucke, Richard Létourneau, MD, Michel Dagenais, MD, Réal Lapointe, MD, André Roy, MD, Hopital Saint Luc-CHUM, Montréal, PQ, Canada.
	187.) Liver resection combined to bile duct repair after a bile duct injury during laparoscopic cholecystectomy
	Franck Vandenbroucke, Marylène Plasse, MD, Richard Létourneau, MD, Michel Dagenais, MD, André Roy, MD, Koen Vermeiren, MD, Réal Lapointe, MD, Hopital Saint Luc-CHUM, Montréal, PQ, Canada.
	188.) Parenchymal Sparing Central Hepatectomy for Hilar Stricture
	John Stauffer, MD, Marjorie Dougherty, PA-C, MPH, Denise Harnois, MD, Nguyen Justin, MD, Mayo Clinic, Jacksonville, FL.
	Oral Posters II (OP – 10) Basic Science II
	Moderators: Max Schmidt, MD, Indianpolis, IN and O. Joe Hines, MD, Los Angeles, CA
	Abstract Numbers 189 – 199
	189.) Age Increases Murine Resting Gallbladder Volume
	Abhishek Mathur, MD, Kyle Yancey, MD, Julia J. Walker, MS, Debao Lu, MD, Deborah A. Swartz-basile, PhD, Attila Nakeeb, MD, Henry A. Pitt, MD, Indiana University, Indianapolis, IN.
	190.) Development of a Reversible Surgical Model of Gallbladder Inflammation and Cholestasis.
	Carlos U Corvera, Jacob G Kirkland, Sanjay Kakar, Lygia Stewart, University of California, San Francisco, San Francisco, CA.
	191.) Challenges in primary steatotic hepatocyte isolation procedures.
	Justin D Ellett, John W Turner, MD, Eric Hall, Zachary P Evans, Kenneth D Chavin, MD, PhD, Medical University of South Carolina, Charleston, SC; Duke University, Durham, NC; CellzDirect, Inc., Pittsboro, NC.
	192.) Hepatic fibrosis induced by xenosera is featured by inconspicuous inflammation but robust ECM remodeling
	Gordon D Wu, Yao He, MD, PhD, Tomohito Sadahiro, MD, Jan Li, PhD, Hui Zhu, MD, PhD, Sangik Noh, MD, Andrew S Klein, MD, Cedars-Sinai Medical Center, Los Angeles, CA.
	193.) Liver Sinusoidal Endothelial Cells: Phenotypic Characterization by Electron Microscopy
	Luis J Garcia, MD, Olivier Rolin, Diego Avella, Eric Kimchi, MD, Kevin Staveley-o'carroll, MD, PhD, Penn State University, Hershey, PA.
	194.) Cellular heterogeneity of hepatic macrophages: Isolation and characterization of two subsets of ED2 (CD163) positive cells in the rat liver
	Gordon D Wu, MD, Yao He, MD, PhD, Tomohito Sadahiro, MD, PhD, Jan Li, PhD, Sang-ik Noh, MD, Hui Zhu, MD, PhD, Andrew S Klein, MD, Cedars-Sinai Medical Center, Los Angeles, CA.
	195.) Withdrawn
	Helge-Kleinhans, MD, Jussuf T Kaifi, MD, Felix Reinknecht, MD, Paulus Gabriel Schurr, MD, Bente Hansen, MS, Oliver Mann, MD, Jakob Robert Izbicki, PhD, Tim G Strate, MD, University Medical Center, Hamburg, Germany.
	196.) Leukocyte-endothelium interactions in acute pancreatitis after TNF-alpha modulation: an intravital microscopic study.
	Andre S Matheus, MD, PhD, Jose Jukemura, MD, Ana Maria M. Coelho, Paulina Sannomiya, PharmD, PhD, Naomi C. Nakagawa, Jose Eduardo M. Da Cunha, MD, PhD, Marcel C. C. Machado, MD, PhD, Dept. of Gastroenterology University of Sao Paulo, Sao Paulo, Brazil; Research Division-Heart Institute (InCor) University of Sao Paulo, Sao Paulo, Brazil.
	197.) The effect of ischaemic preconditioning in human liver sinusoidal endothelial cells following hypoxia-reoxygenation
	Dhanwant Gomez, Ann Graham, Nicholas Orsi, Uma Ekbote, Lance Burns, Shervanthi Homer-vanniasinkam, K.rajendra Prasad, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom; University of Bradford, Bradford, United Kingdom; Leeds Institution of Molecular Biology, Leeds, United Kingdom; Department of Clinical Sciences, Sheffield, United Kingdom.
	198.) Ischemic Preconditioning and Intermittent Clamping Increase the Tolerance of Fatty Liver to Hepatic Ischemia-Reperfusion Injury in the Rat
	Reza F Saidi, MD, Jennifer Chang, MD, Steven Verb, MD, Steven Brooks, MD, I Nalbantoglu, MD, Volkan Adsay, MD, Michael J Jacobs, MD, Providence Hospital and Medical Centers, Southfield, MI; Detroit Medical Center, Detroit, MI.
	199.) Ischaemic preconditioning versus intermittent clamping on human liver sinusoidal endothelial cells: Effects on cytokines and growth factors
	Dhanwant Gomez, Ann Graham, Nicholas Orsi, Uma Ekbote, Lance Burns, Shervanthi Homer-vanniasinkam, K.rajendra Prasad, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom; University of Bradford, Bradford, United Kingdom; Leeds Institution of Molecular Biology, Leeds, United Kingdom; University of Sheffield, Sheffield, United Kingdom.
	Oral Posters II (OP – 11) Pancreas II: Techniques, Neoplasm Potpourri
	Moderators: Craig Fischer, MD, Hoston, TX and Tom Howard, MD, Indianapolis, IN
	Abstract Numbers 200 – 211
	200.) A Single-Institution Retrospective Review Of Laparoscopic And Open Distal Pancreatectomies
	Beth Schrope, MD, PhD, John Allendorf, MD, Joseph Dinorcia, MD, Aliye Bill, None, Mary Digiorgi, MS, John Chabot, MD, Columbia University, New York, NY.
	201.) Open and Laparoscopic Spleen-Preserving, Splenic Vessel-Preserving Distal Pancreatectomy: Indications and Outcomes
	Matias Bruzoni, MD, Aaron R Sasson, MD, University of Nebraska Medical Center, Omaha, NE.
	202.) Cystic Pancreatic Neuroendocrine Tumors: A Rare Entity?
	Marshall S Baker, MD, MBA, John M Dewitt, MD, Pradermchai Kognkam, MD, Julia K Leblanc, MD, Harvey M Cramer, MD, Thomas J Howard, MD, C Max Schmidt, MD, PhD, Keith D Lillemoe, MD, Henry A Pitt, MD, Indiana University Medical Center, Indianapolis, IN.
	203.) Cystic Pancreatic Neoplams: An emerging problem.
	Kamran M. H. Karimi, MD, Irfan A. Rizvi, MD, Magesh Sundaram, MD, Harold J. Williams, MD, David W. Mcfadden, MD, WEST VIRGINIA UNIVERSITY, Morgantown, WV.
	204.) Current Diagnosis and Management of Solid Pseudopapillary Tumors of the Pancreas
	Gregory Watson, MD, Kevin Mcgrath, MD, Niraj Jani, MD, Kenneth Lee, MD, University of Pittsburgh, Pittsburgh, PA.
	205.) Incidence, Prevalence and Management of Intraductal Papillary Mucinous Neoplasm in Olmsted County, Minnesota, 1976-2005; A population study
	Kaye M Reid Lombardo, MD, Jennifer St. Sauver, PhD, Zhou Li, MS, William A Ahrens, MD, K. Krishnan Unni, Florencia G. Que, MD, Mayo Clinic, Rochester, MN.
	206.) Is Surgery necessary for The Treatment of Preoperative Diagnosed Ampulla of Vater Adenoma?
	Dong-sup Yoon, Joon Seong Park, MD, Kyung-sik Kim, MD, PhD, Jin Sub Choi, MD, Woo-jung Lee, MD, PhD, Hoon-sang Chi, MD, PhD, Byung-ro Kim, MD, PhD, Yonsei University Medical College, Seoul, Republic of Korea.
	207.) Somatostatinoma: A 20-year surgical experience.
	Gerard Abood, MD, Asghar Rizvi, None, Gerard Aranha, MD, Sherri Yong, MD, Margo Shoup, MD, Loyola University Medical Center, Maywood, IL.
	208.) Is There an Indication for Initial Conservative Management of Cystic Lesions of the Pancreas?
	Stephen R Grobmyer, MD, Steven N. Hochwald, MD, William G. Cance, MD, Stephen B. Vogel, MD, University of Florida, Gainesville, FL.
	209.) Frantz-Gruber Tumor-A Spectrum of Diseases and Surgical Treatment Options: Pancreaticoduodenectomy to Laparoscopic Distal Pancreatectomy
	Sean Garrean, MD, Justin Hering, MD, Barney Dillard, MD, Abdul Saied, MD, William Scott Helton, MD, Nocif Joseph Espat, MD, University of Illinois at Chicago, Chicago, IL.
	210.) Outcomes following aggressive surgery for malignant neuroendocrine tumours of the pancreas
	Glenn K Bonney, MBBS, Dhanwant Gomez, Caroline Verbeke, Sakhawat Rahman, Michael Mcmahon, Giles Toogood, K. Rajendra Prasad, J.peter Lodge, Krishna Menon, St James' University Hospital, Leeds, United Kingdom; St James' University Hospital, Leeds Ls9 7tf, United Kingdom.
	211.) Is Resection of Periampullary or Pancreatic Adenocarcinoma with Synchronous Hepatic Metastases Justified?
	Timothy M Pawlik, MD, MPH, Ana Gleisner, MD, Jordan Winter, MD, Michael Choti, MD, MBA, Richard Schulick, MD, John Cameron, MD, Johns Hopkins, Baltimore, MD.
	Oral Posters II (OP – 12) Pancreas III: Staging, Prognosis, Technical Issues
	Moderators: Attilla Nakeeb, MD, Indianpolis, IN and Stuart Marcus, MD, Bridgeport, CT
	Abstract Numbers 212 – 222
	212.) The Role Of Pancreaticoduodenectomy In The Treatment Of Complex Pancreatic Trauma
	Alexander R Karamarkovic, MD, PhD, University Center for Emergency Surgery, School of Medicine University of Belgrade, Belgrade, Serbia and Montenegro.
	213.) Anthropometric Assessment Of The “Staging Window” Prior To Pancreaticoduodenectomy.
	Kolitha S Goonetilleke, MBBS, Sorrel Burden, PhD, Ajith K Siriwardena, HPB Unit, Dept of Surgery, Manchester Royal Infirmary, Manchester, United Kingdom; Dept of Nutrition and Dietetics, Manchester Royal Infirmary, United Kingdom.
	214.) Characterization of Peri-operative Bleeding and Transfusion Utilization in a Modern Series of Pancreaticoduodenectomies
	Matthew J. Delano, MD, Steven N. Hochwald, MD, Chris A. Garces, MD, William G. Cance, MD, Stephen R. Grobmyer, MD, University of Florida, Gainesville, FL.
	215.) Modified Catell's Pancreatico-jejunostomy, buttressing and isolated bilio-pancreatic loop results in better outcomes following Pancreaticoduodenectomy
	Mohammad Abu-hilal, Hamilton-burke Wurbena, Glenn K Bonney, Krishna V Menon, St James' University Hospital, Leeds Ls9 7tf, United Kingdom.
	216.) Surgical Aspects Of Liver Arterialization After Pancreatectomy With Celiac Axis Resection For Locally Advanced Cancer Of The Pancreatic Body
	Emilio Vicente, MD, PhD, Yolanda Quijano, MD, PhD, Carmelo Loinaz, MD, PhD, Ramon D Conradi, MD, Fabiola Maches, MD, Luis Cordoba, MD, Elena Ayerbe, MD, Enrique Niembro, MD, Hospital Madrid-Monteprincipe, Boadilla Del Monte, Madrid, Spain.
	217.) Nodal sampling in periampullary cancer: Does it change your approach?
	Roozbeh Rassadi, MD, Dhiresh Rohan Jeyarajah, MD, Dallas Methodist Medical Center, Dallas, TX.
	218.) Lymph Node Ratio As A Predictive Factor In Pancreatic Adenocarcinoma
	Mohamed Alassas, J Wang, S Agrawal, J Parsons, K Stephen, J Wrozek, I Fung, J.f. Gibbs, Roswellpark cancer institute, Buffalo, NY; SUNY, Buffalo, NY.
	219.) Role of Preoperative 18-FDG-PET in Pancreatic Masses
	Marjorie K Dougherty, PA-C, MPH, Justin Nguyen, MD, Mayo Clinic Jacksonville, Jacksonville, FL.
	220.) Pancreatic resection for metastatic renal cell carcinoma to the pancreas.
	Kamran M. H. Karimi, MD, David W. Mcfadden, MD, WEST VIRGINIA UNIVERSITY, Morgantown, WV.
	221.) Unusual Early And Late Complications Of Pancreaticoduodenectomy: Recognition Is Paramount To Diagnosis
	Nicholas J Zyromski, MD, Attila Nakeeb, C. Max Schmidt, MD, PhD, Henry A Pitt, MD, Keith D Lillemoe, MD, Thomas J Howard, MD, Indiana University, Indianapolis, IN.
	222.) Life-threatening bleeding from duodenum due to pancreatic diseases.
	Yuki Sakuraoka, MD, Mitsugi Shimoda, MD, PhD, Masato Katoh, MD, PhD, Kyu Rokkaku, MD, PhD, Tokihiko Sawada, MD, PhD, Keiichi Kubota, MD, PhD, Dokkyo Univ, School of Med., Mibu, Tochigi, Japan.
	Oral Posters II (OP – 13) Liver IV: Metastatic Disease
	Moderators: Bill Hawkins, MD, St. Louis, MO and Rick Selby, MD, Los Angeles, CA
	Abstract Numbers 223 – 234
	223.) Surgical interventions for metastatic lesions to the liver: a national perspective
	James T Mcphee, MD, Joshua S Hill, MD, Zachary Hurwitz, MS, Giles F Whalen, MD, Mary E Sullivan, RN, Jennifer F Tseng, MD, University of Massachusetts Medical School, Worcester, MA.
	224.) Multimodal Treatment of Liver Metastasis from Gastrointestinal Stromal Tumours
	Osama M Damrah, Peter Sipos, Long Jiao, Nagy Habib, Hapreet Wasan, Ruben Canelo, Hammersmith Hospital, London, United Kingdom.
	225.) Hepatic resection for metastatic gastro-intestinal and pancreatic neuroendocrine tumours: Outcome and prognostic predictors
	Dhanwant Gomez, Karim Halazun, Ahmed Al-mukthar, Krishna V Menon, Giles J Toogood, J. Peter A Lodge, K. Rajendra Prasad, Leeds Teaching Hospitals NHS Trust, Leeds, Ls9 7tf, United Kingdom.
	226.) Partial hepatectomy for hepatic neuroendocrine malignancy: who benefits?
	Clifford S Cho, MD, Daniel M Labow, MD, Jinru Shia, MD, David S. Klimstra, MD, Mithat Gonen, PhD, William R. Jarnagin, MD, Michael I. D'angelica, MD, Leslie H. Blumgart, MD, Ronald P. Dematteo, MD, University of Wisconsin School of Medicine and Public Health, Madison, WI; Memorial Sloan-Kettering Cancer Center, New York, NY.
	227.) Simultaneous Resection Of Colorectal Tumors And Liver Metastases
	Juan Francisco Guerra Castro, MD, Enrique Norero, MD, Jorge Martínez, MD, George Pinedo, MD, Michel Butte, MD, Luis Ibañez, MD, Nicolás Jarufe, MD, Universidad Católica de Chile, Santiago De Chile, Chile.
	228.) Survival after resection of hepatic and pulmonary colorectal metastases
	Srinevas K Reddy, Andrew S. Barbas, MD, Thomas A. D'amico, MD, David H. Harpole Jr., MD, William R. Burfeind Jr., MD, Bryan M. Clary, MD, Duke University Medical Center, Durham, NC.
	229.) Outcomes after hepatic resection in the patients with colorectal cancer liver metastases: a retrospective comparison with non-resection cases
	Hyung-chul Kim, MD, PhD, Jong Woo Joo, MD, Chun Jun Cho, MD, Nam Kyu Choi, Hee Jae Lee, SoonChunHyang University Hospital, Bucheon,gyeonggi Do, Republic Of Korea, Republic of Korea; Ansan Jungang WAM Hospital, Ansan,gyeonggi Do, Republic Of Korea, Republic of Korea.
	230.) Prognostic factors in Hepatic Resections for the Colorectal cancer metastases
	Alexander R Karamarkovic, MD, PhD, University Center for Emergency Surgery, Belgrade, Serbia and Montenegro.
	231.) Predictors of early disease recurrence following hepatic resection for colorectal cancer metastasis
	Hassan Z Malik, Dhanwant Gomez, Giles J Toogood, J. Peter A Lodge, K. Rajendra Prasad, Leeds Teaching Hospitals NHS Trust, Leeds, Ls9 7tf, United Kingdom.
	232.) The Pathology Of Liver Nodules After Neoadjuvant Chemotherapy Is Associated With Outcome For Colorectal Cancer Metastases.
	Gabriel Chan, MD, Mazen Hassanain, MBBS, Prosanto Chaudhury, MD, Tamara Znajda, MD, Ryan Coughlin, B.Sc., Peter Metrakos, MD, Royal Victoria Hospital, McGill University Health Centre, Montreal, PQ, Canada.
	233.) Withdrawn
	234.) Resection for colorectal and non-colorectal liver metastases. A comparative study
	Ricardo Joaquin Mondragon-sanchez 80, MD, PhD, Rodrigo Jasso-barranco 2006, MD, Elvira Gomez-gomez 2003, MD, Alejandro Mondragon-sanchez 80, MD, Ofelia Arias-arias 2005, MD, Brenda Elena Aguilar-alvarez 2005, MD, Alicia Ivette Lopez-estrada 2006, MD, issemym, Toluca, Mexico.

	Oral Posters II (OP – 14) Liver V: Ablation
	Moderators: Francis Sutherland, MD, Calgary, AB and Alex Parikh, MD, Nashville, TN
	Abstract Number 235 – 246
	235.) An Experimental study of the treatment of liver injury with InLine RFA
	Peng Yao, Steve Daniel, Aravin Gunasegaram, David L Morris, The University of New South Wales, Sydney, Australia.
	236.) Benign Liver Tumors: Role for Laparoscopic Ultrasound-Guided Radiofrequency Ablation
	Dmitri Alden, MD, Vassar Brothers Medical Center, Poughkeepsie, NY.
	237.) The heat sink effect may lead to local recurrence: a comparative study of Radiofrequency, cryotherapy and microwave in the liver.
	Neil Bhardwaj, Andrew D Strickland, MBBS, Lilit Atanesyan, MBBS, Fateh Ahmad, MBBS, Kevin West, David M Lloyd, MBBS, Leicester Royal Infirmary, Leicester, United Kingdom.
	238.) Liver Resection Using a Four-Prong Radiofrequency Coagulation Device (Habib 4X, RITA Medical)
	Byrne Lee, MD, Lawrence D. Wagman, MD, City of Hope National Medical Center, Duarte, CA.
	239.) A multicentre control study of InLine radiofrequency ablation device for liver transection
	David L Morris, Frank Chu, Peng Yao, Steve Daniel, Aravin Gunasegaram, Tristan Yan, Werner Lindemann, Georg Pistorius, Martin Schilling, Junji Machi, Randall Zuckerman, The University of New South Wales, Sydney, Australia; Saarland University Hospital, Saarbrücken, Germany; University of Hawaii, Hawaii, HI; Bassett Health Care, Cooperstown, NY.
	240.) Radiofrequency Ablation of Small Hepatic Malignancies Provides Equal Local Control to Resection
	Eric C Feliberti, MD, Rebecca A. Nelson, PhD, Alicia Holt, MD, Jonathan Roybal, Layla Rouse, MS, Lawrence D Wagman, MD, Eastern Virginia Medical School, Norfolk, VA; City of Hope National Medical Center, Duarte, CA.
	241.) Is Radiofrequency-assisted liver resection safe and oncologically-sound?
	Giles Smith, MBBS, Marco Bertucci, MD, Duncan Spalding, MD, MBBS, Robert Hutchins, MD, MBBS, Royal London Hospital, London, United Kingdom; Hammersmith Hospital, London, United Kingdom.
	242.) The Evolution and Perioperative Course of Patients Undergoing Radiofrequency Ablation of Liver Tumors Between 1996 and 2006
	Paul Hansen, Y Khajanchee, M Cassera, W Alexander, C Wilson, Legacy Health System, Portland, OR.
	243.) Resection of Hepatic Recurrence Following Radiofrequency Ablation for Liver Metastases
	Brian Badgwell, MD, Jean Nicolas Vauthey, MD, Dario Ribero, MD, Steven A Curley, MD, Eddie K Abdalla, MD, M.D. Anderson Cancer Center, Houston, TX.
	244.) Survival Results of Non-Surgical Treatment Modalities for Malignant Liver Tumours
	Hassan Garba, Osama M Damrah, Paul Tait, Hapreet Wasan, Long Jiao, Nagy Habib, Ruben Canelo, Hammersmith Hospital, London, United Kingdom.
	245.) Microwave ablation is an effective tool to treat unresectable primary and secondary liver tumours.
	Neil Bhardwaj, MBBS, Andrew D Strickland, MBBS, Ahmad Fateh, MBBS, Moshier El-abassy, MBBS, Lloyd M David, MBBS, Leicester Royal Infirmary, Leicester, United Kingdom.
	246.) Novel High Speed Radio Frequency (HSRF) Tissue Ablation System-Initial Clinical Experience
	David L Morris, MD, PhD, Steve Daniel, PhD, Frank K Chu, MBBS, Kee Lee, None, The University of New South Wales, Sydney, Australia.

7:00 – 10:00 p.m.

Congress Banquet

(Skyview Room)

Sunday, April 22^nd, 2007

7:30 – 12:00 p.m.	Meeting Registration	(Lobby, Bally's Hotel)
7:30 – 9:30 a.m.	Symposium	(Pacific Ballroom)
	Peri-Ampullary and Duodenal Lesions
	Moderators: Bryan Clary, MD, Durham, NC and Robert Glasgow, MD, Nashville, TN
	Speakers: John Baillie, MD, Winston-Salem, NC
	Sphincter of Oddi Dysfunction
	Clifford Cho, MD, Madison, WI
	Duodenal / Ampullary Neuroendocrine Tumors
	Randall Burt, MD, Salt Lake City, UT
	Duodenal / Ampullary Adenomas – Sporadic & Syndromic
	Paul Yeaton, MD, Charlottesville, VA
	Endoscopic Approaches to Duodenal / Ampullary Lesions
	Douglas Tyler, MD, Durham, NC
	Surgical Resection of Duodenal and Ampullary Tumors
	Panel discussion, clinical cases by the moderator.

7:30 – 9:30 a.m.

ParallelFree Paper Session: HPB Potpourri

(Las Vegas)

	Free Papers (FP – 08) HPB Potpourri
	Abstract Numbers 247 – 254
	247.) A standardized approach to teaching laparoscopic cholecystectomy eliminates common bile duct injury in an inner city University teaching hospital
	Marco Fisichella, MD, N. Joseph Espat, MD, Subashini Ayloo, MD, Phillip Donahue, MD, Joseph Vitello, MD, Robert Berger, MD, W. Scott Helton, MD, University of Illinois at Chicago, Chicago, IL; University of Illinois at Chicago, Chicago, IL; Flagstaff Hospital, Flagstaff, AZ; Hospital of Saint Raphael, New Haven, CT.
	248.) Microwave ablation is extremely effective at gaining local control of large liver tumours.
	Neil Bhardwaj, Andrew D Strickland, MBBS, Fateh Ahmad, MBBS, Moshier Elabassy, MBBS, David M Lloyd, MBBS, Leicester Royal Infirmary, Leicester, United Kingdom.
	249.) Preoperative staging for extrahepatic cholangiocarcinoma using MDCT prior to biliary drainage
	Katsuhiko Uesaka, MD, PhD, Atsuyuki Maeda, MD, PhD, Kazuya Matsunaga, MD, Hideyuki Kanemoto, MD, Hiroyoshi Furukawa, MD, PhD, Shizuoka Cancer Center, Shizuoka, Japan.
	250.) CT vs. MRCP: optimal classification of IPMN
	Joshua A Waters, Jason W Pinchot, MD, Patrick B White, Henry A Pitt, MD, Kumar Sandrasegaran, MD, Fatih M Akisik, MD, Thomas J Howard, MD, Atilla Nakeeb, MD, Nicholas J Zyromski, MD, Keith D. Lillemoe, MD, C Max Schmidt, MD, PhD, Indiana University, Indianapolis, IN.
	251.) Antral Preserving Pancreatoduodenectomy: Impact on early post-operative delayed gastric emptying.
	Paul D Renfrew, MD, Francis R Sutherland, MD, Tom Baker Cancer Center, Calgary, AB, Canada.
	252.) Does Pancreatic Duct Size Predict The Risk Of Fistula After Pancreaticoduodenectomy?
	Lynt B Johnson, Reena Jha, MD, Naddim Haddad, MD, Firas Al-kawas, MD, John Carroll, MD, Thomas Fishbein, MD, Georgetown Univ Hospital, Washington, DC.
	253.) Self-expandable enteral metallic stents for treatment of gastric outlet obstruction: a single centre experience in 67 patients.
	Franck Vandenbroucke, MD, Marylène Plasse Plasse, Richard Létourneau, MD, Michel Dagenais, MD, Réal Lapointe, MD, André Roy, MD, Hopital Saint Luc-CHUM, Montréal, PQ, Canada.
	254.) Laparoscopic Distal Pancreatectomy: Comparison With Open Surgery
	Attila Nakeeb, MD, C. Max Schmidt, MD, PhD, Thomas J. Howard, MD, Nicholas J Zyromski, MD, Keith D Lillemoe, MD, Henry A Pitt, MD, Indiana University School of Medicine, Indianapolis, IN.

7:30 – 9:30 a.m.

ParallelFree Paper Session: Liver

(Las Vegas)

	Free Papers (FP – 09) Liver II
	Abstract Numbers 255 – 262
	255.) Clinicogenomic Characterization Of Primary Colorectal Carcinoma Associated With Liver Metastases
	K Meredith, MD, E Siegel, J Mcloughlin, MD, R Nair, MD, J Lewis, MD, S Eschrich, PhD, G Bloom, PhD, Q Ly, MD, E Jensen, MD, M Alvarado, MD, T Yeatman, MD, D Shibata, MD, H. Lee Moffitt Cancer Center, Tampa, FL.
	256.) Neoadjuvant chemotherapy prior to major hepatic resection of colorectal metastases is associated with increased mortality and higher complications rate
	Ory Weisel, Nir Lubezky, Ravit Geva, Einat Shmueli, Arie Figer, Richard Nakache, Menahem Ben-haim, Tel Aviv medical center, Tel-aviv, Israel.
	257.) Total Loss of FDG Avidity in Colorectal Cancer Liver Metastases after Chemotherapy is Infrequently Associated with a Complete Pathological Response
	Marcus C Tan, MBBS, David C Linehan, MD, William G Hawkins, MD, Steven M Strasberg, MD, Barnes-Jewish Hospital / Washington University School of Medicine, St. Louis, MO.
	258.) Right Hepatic Lobectomy Using the Staple Technique in 101 Patients
	Fady K Balaa, MD, Allan Tsung, MD, T. Clark Gamblin, MD, J. Wallis Marsh, MD, David A Geller, MD, UPMC Liver Cancer Center, University of Pittsburgh, Pittsburgh, PA.
	259.) Hepatectomy following colorectal cancer resection in the elderly in the United States
	Jensen C. C. Tan, MD, Natalie G. Coburn, MD, Calvin H. L. Law, MD, University of Toronto, Toronto, ON, Canada.
	260.) Recurrence and Survival Outcomes after Hepatic Resection with and without Cryotherapy for Colorectal Liver Metastases
	Rui Niu, Tristan D Yan, MBBS, Jacqui C Zhu, Francis Chu, MBBS, David L Morris, MD, PhD, St George Hospital, Sydney, Australia.
	261.) Colorectal Liver Metastases: Recurrence and Survival Following Hepatic Resection, Radiofrequency Ablation, and Combined Resection/Ablation
	TimothyM Pawlik, MD, MPH, Lia R Assumpcao, MD, Ana Gleisner, MD, Michael Choti, MD, MBA, Johns Hopkins, Baltimore, MD.
	262.) Microwave Hepatic Tumor Ablation Results of ongoing Phase 2 Trial
	Robert Cg Martin, MD, Kelly M Mcmasters, MD, PhD, David A. Iannitti, MD, Damian E. Dupuy, MD, University of Louisville, Louisville, KY; Carolinas Medical Center, Charlotte, NC; Brown Medical School, Providence, RI.

9:30 – 9:45 a.m.	Coffee break
9:45 – 10:10 a.m.	State of the Art Address	(Pacific Ballroom)
	“Assessing Resectibility on Preoperative Imaging: Indentification and Management of Borderline Resectable Pancreatic Cancer”
	Speaker: Douglas Evans, MD, Houston, TX
10:15 – 11:45 a.m.	Symposium	(Pacific Ballroom)
	HPB Training – Toward A Competency Based Model
	Moderators: Rebecca Minter, MD, Ann Arbor, MI and Scott Helton, MD, New Haven, CT
	Speakers: Richard Bell, MD, Philadelphia, PA
	Overview of Competency Based / Modular Training
	Paul Greig, MD, Toronto, ON
	A Competency Based HPB Program
	Presidents Panel
	Henry Pitt, MD, Indianapolis, IN; Steve Strasberg, MD, St. Louis, MO; C. Wright Pinson, MD, Nashville, TN; Ted Pappas, MD, Durham, NC
	Panel and Audience Discussion

10:15 – 11:45 a.m.	ParallelFree Papers Session: Biliary II	(Las Vegas)
	Free Papers (FP – 10) Biliary II
	Abstract Numbers 263 – 268
	263.) Gallbladder bile changes in patients treated with preoperative total parenteral nutrition.
	Lillian G. Dawes, MD, Steven J. Stryker, MD, University of Michigan, Ann Arbor, MI; Northwestern University Feinberg School of Medicine, Chicago, IL.
	264.) Unconscious Bias Influences the Diagnosis of Laparoscopic Bile Duct Injuries
	Lygia Stewart, MD, Lawrence W. Way, MD, UCSF, San Francisco, CA.
	265.) Evolution of the Surgical Repair of bile duct injuries. The transition to intrahepatic repair.
	Miguel Angel Mercado, MD., Instituto Nacional de la Nutrición Salvador Zubirán, Mexico City, Mexico.
	266.) Treatment of major bile duct injuries after laparoscopic cholecystectomy-fifteen year experience in a reference center.
	Franck Vandenbroucke, Koen Vermeiren, Marylène Plasse, MD, Richard Létourneau, MD, Michel Dagenais, MD, André Roy, MD, Réal Lapointe, MD, Hopital Saint Luc-CHUM, Montréal, PQ, Canada.
	267.) Management of Benign Biliary Strictures: Analysis of Minimally Invasive Techniques versus Surgical Treatment
	Osama M Damrah, Andrea Lauretta, Long R Jiao, Nagy A Habib, Ruben Canelo, Hammersmith Hospital, London, United Kingdom.
	268.) Recurrent Pyogenic Cholangitis-The Role of Surgical Intervention.
	Wigdan R Al-sukhni, MD, Steven Gallinger, MD, FRCP, Alice C Wei, MD, FRCP, Chia Sing Ho, MD, FRCP, Paul Kortan, MD, FRCP, Paul D Greig, MD, FRCP, Toronto General Hospital-University of Toronto, Toronto, ON, Canada; Mount Sinai Hospital-University of Toronto, Toronto, ON, Canada; St. Michael's Hospital-University of Toronto, Toronto, ON, Canada.
10:15 – 11:45 a.m.	ParallelFree Papers Session: Liver III	(Las Vegas)
	Free Papers (FP – 11) Liver III
	Abstract Numbers 269 – 274
	269.) Comparison of two methods of future liver remnant volume measurement
	Yun Shin Chun, MD, Dario Ribero, MD, Eddie K. Abdalla, MD, David C. Madoff, MD, Melinda M. Mortenson, MD, Jean Nicolas Vauthey, MD, MD Anderson Cancer Center, Houston, TX.
	270.) Steatosis is an independent predictor of post-operative morbidity following hepatic resection for colorectal metastasis
	Dhanwant Gomez, Hassan Z Malik, Glenn K Bonney, Vincent Wong, Giles J Toogood, J. Peter A Lodge, K. Rajendra Prasad, Leeds Teaching Hospitals NHS Trust, Leeds, Ls9 7tf, United Kingdom.
	271.) Increased Use of Parenchymal-Sparing Surgery for Bilobar Colorectal Liver Metastases is Associated with Reduced Mortality without Change in Oncologic Outcome
	Jason S. Gold, Chandrakanth Are, Peter Kornprat, William R. Jarnagin, Mithat Gönen, Yuman Fong, Ronald P. Dematteo, Leslie H. Blumgart, Michael D'angelica, Memorial Sloan-Kettering Cancer Center, New York, NY.
	272.) Resectable Extrahepatic Disease is No Longer a Contraindication to Hepatectomy for Colorectal Metastases
	Ryan L Neff, MD, Osama Al-saif, MD, Colin Brady, MD, Edward Martin, MD, Mark Bloomston, MD, Ohio State University, Columbus, OH.
	273.) Survival Following Radiofrequency Ablation of Colorectal Liver Metastases: A Ten Year Experience
	Peter Denk, MD, Yashodhan S Khajanchee, MD, Whitney Alexander, Paul Daniel Hansen, MD, M Cassera, C Wilson, Lagacy Health System, Portland, OR; Oregon Clinic, Portland, OR.
	274.) Hepatectomy and Lung Radiofrequency Ablation for Hepatic and Subsequent Pulmonary Metastases from Colorectal Carcinoma
	Sivapirabu Sathasivam, MD, Tristan D. Yan, MD, Julie King, MPH, Derek Glenn, MD, David L Morris, MD, PhD, Department of Surgery and Radiology, St George Hospital, Sydney, New South Wales, Australia.
11:45 – 12:00 p.m.	Closing Address:      (Pacific Ballroom)
	Bruce Schirmer, M.D.
	AHPBA President
	University of Virginia, Charlottesville, Virginia